###begin article-title 0
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 145 147 145 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2">S&#8414;</xref>
###xml 147 147 147 147 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn3"/>
Functional Significance of the Interaction between the mRNA-binding Protein, Nab2, and the Nuclear Pore-associated Protein, Mlp1, in mRNA Export*Sâƒž
###end article-title 0
###begin p 1
###xml 129 146 129 146 <email xmlns:xlink="http://www.w3.org/1999/xlink">acorbe2@emory.edu</email>
 To whom correspondence should be addressed: 1510 Clifton Rd., Atlanta, GA 30322. Tel.: 404-727-4546; Fax: 404-727-2738; E-mail: acorbe2@emory.edu.
###end p 1
###begin p 2
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 2
###begin p 3
 applies to Author Choice Articles
###end p 3
###begin p 4
###xml 178 202 178 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 754 756 754 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 883 891 883 891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1079 1086 1079 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1459 1468 1459 1468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1547 1552 1547 1552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEX67</italic>
###xml 1557 1561 1557 1561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YRA1</italic>
###xml 1582 1589 1582 1589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 178 202 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Nuclear export of mRNA requires several key mRNA-binding proteins that recognize and remodel the mRNA and target it for export via interactions with the nuclear pore complex. In Saccharomyces cerevisiae, the shuttling heterogeneous nuclear ribonucleoprotein, Nab2, which is essential for mRNA export, specifically recognizes poly(A) RNA and binds to the nuclear pore-associated protein, myosin-like protein 1 (Mlp1), which functions in mRNA export and quality control. Specifically, the N-terminal domain of Nab2 (Nab2-N; residues 1-97) interacts directly with the C-terminal globular domain of Mlp1 (CT-Mlp1: residues 1490-1875). Recent structural and binding studies focused on Nab2-N have shown that Nab2-N contains a hydrophobic patch centered on Phe73 that is critical for interaction with Mlp1. Engineered amino acid changes within this patch disrupt the Nab2/Mlp1 interaction in vitro. Given the importance of Nab2 and Mlp1 to mRNA export, we have examined the Nab2/Mlp1 interaction in greater detail and analyzed the functional consequences of disrupting the interaction in vivo. We find that the Nab2-binding domain of Mlp1 (Mlp1-NBD) maps to a 183-residue region (residues 1586-1768) within CT-Mlp1, binds directly to Nab2 with micromolar affinity, and confers nuclear accumulation of poly(A) RNA. Furthermore, we show that cells expressing a Nab2 F73D mutant that cannot interact with Mlp1 exhibit nuclear accumulation of poly(A) RNA and that this nab2 F73D mutant genetically interacts with alleles of two essential mRNA export genes, MEX67 and YRA1. These data provide in vivo evidence for a model of mRNA export in which Nab2 is important for targeting mRNAs to the nuclear pore for export.
###end p 4
###begin p 5
###xml 51 80 51 80 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">National Institutes of Health</grant-sponsor>
###xml 136 160 136 160 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust Programme</grant-sponsor>
###xml 320 333 320 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
This work was supported, in whole or in part, by a National Institutes of Health grant (to A. H. C.). This work was also supported by a Wellcome Trust Programme Grant (to M. S.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 5
###begin p 6
The on-line version of this article (available at ) contains supplemental Fig. S1 and Table S1.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 117 118 117 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 119 120 119 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 346 347 346 347 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 490 491 490 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">2</xref>
###xml 753 754 753 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 755 756 755 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 758 759 758 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 915 916 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 918 919 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
Production of mature mRNA for translation is a complex multistep process involving an array of RNA-binding proteins (1-3). From its transcriptional inception in the nucleus, pre-mRNA that emerges from RNA polymerase II must be bound by processing factors for 5'-end capping, splicing, and 3'-end cleavage and polyadenylation to reach maturation (4). Alongside these processing events, maturing mRNA must be co-transcriptionally loaded with heterogeneous nuclear ribonucleoproteins (hnRNPs),2 mRNA export adaptors, and an mRNA export receptor to facilitate its active export from the nucleus to the cytoplasm through nuclear pore complexes (NPCs), large proteinaceous channels that perforate the nuclear membrane and mediate nucleocytoplasmic transport (1-3, 5). There are a number of nuclear quality controls that safeguard against improperly processed mRNA being exported and translated into deleterious proteins (6, 7). In particular, this quality control machinery likely monitors the state of processed mRNA by checking for the presence or absence of mRNA processing and export factors.
###end p 8
###begin p 9
###xml 192 240 192 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae, Caenorhabditis elegans</italic>
###xml 246 269 246 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila melanogaster</italic>
###xml 328 329 328 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 338 351 338 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 492 493 492 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 760 762 760 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 763 765 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 192 216 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 218 240 <span type="species:ncbi:6239">Caenorhabditis elegans</span>
###xml 246 269 <span type="species:ncbi:7227">Drosophila melanogaster</span>
###xml 338 351 <span type="species:ncbi:4932">S. cerevisiae</span>
One of the key players in mRNA export is the conserved heterodimeric mRNA export receptor, Mex67/Mtr2 (NXF1/NXT1 or TAP/p15 in metazoans), which plays an essential role in bulk mRNA export in Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila melanogaster and stimulates export of transcripts in vertebrate cells (8-12). In S. cerevisiae, a temperature-sensitive mutant of Mex67, mex67-5, shows significant nuclear accumulation of poly(A) RNA at the non-permissive temperature (8). The Mex67/Mtr2 heterodimer interacts directly with phenylalanine-glycine (FG) repeat-containing nuclear pore proteins (nucleoporins or Nups) in the NPC, which facilitates translocation of the receptor with its mRNA cargo through the transport channel of the pore (12-17).
###end p 9
###begin p 10
###xml 261 263 261 263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 264 266 264 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 272 285 272 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 360 366 360 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 586 596 586 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 600 610 600 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 704 717 704 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 719 721 719 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 863 876 863 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 1020 1022 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 272 285 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 600 610 <span type="species:ncbi:6239">C. elegans</span>
###xml 704 717 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 807 812 <span type="species:ncbi:4932">yeast</span>
###xml 863 876 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 928 933 <span type="species:ncbi:4932">yeast</span>
In addition to the Mex67/Mtr2 receptor, efficient mRNA export also requires mRNA adaptors. The most well characterized mRNA adaptor is the evolutionarily conserved protein, Yra1 (Aly/REF in metazoans), which binds to RNA and recruits Mex67/Mtr2 to transcripts (18-20). In S. cerevisiae, Yra1 is essential for mRNA export and thermosensitive alleles, including yra1-8, show nuclear accumulation of poly(A) RNA at the non-permissive temperature (18, 21). In vertebrates, Aly/REF also mediates mRNA export (22, 23). Interestingly, however, Aly/REF is not essential for bulk mRNA export in Drosophila or C. elegans and Yra1 only binds to about 1000 mRNA transcripts, representing one-fifth of the genome, in S. cerevisiae (24-26). These results suggest that different mRNA adaptors can operate in metazoans and yeast. An example of an alternative mRNA adaptor is the S. cerevisiae hnRNP, Npl3, which is essential for mRNA export in yeast, associates with mRNA co-transcriptionally, and can bind to the Mex67 export protein (27-31).
###end p 10
###begin p 11
###xml 45 58 45 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 142 144 142 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 245 247 245 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 253 255 253 255 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 449 451 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 552 554 552 554 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref31">31</xref>
###xml 556 558 556 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 560 562 560 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 716 723 716 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 792 803 792 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2-1/nab2</italic>
###xml 809 810 805 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 933 935 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 45 58 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 132 137 <span type="species:ncbi:4932">yeast</span>
###xml 576 581 <span type="species:ncbi:9606">human</span>
Another potential mRNA export adaptor is the S. cerevisiae hnRNP, Nab2, which is a zinc finger protein essential for mRNA export in yeast (32-34). Nuclear abundant poly(A) RNA-binding protein 2 (Nab2) shuttles between the nucleus and cytoplasm (31, 32, 35) and contains three key functional domains: an N-terminal domain (residues 1-97) involved in mRNA export (36), an RGG domain (residues 201-265) that acts as the nuclear import signal for Nab2 (37), and a C-terminal zinc finger domain (residues 262-477) that specifically binds polyadenosine RNA (31, 34, 36). A putative human orthologue of Nab2, ZC3H14, has a similar domain structure (34). The N-terminal domain of Nab2 (Nab2-N) is critical for Nab2 function in vivo and a Nab2 mutant that lacks the N-terminal domain (residues 4-97), nab2-1/nab2 DeltaN, confers a severe growth defect and nuclear accumulation of poly(A) RNA when expressed as the sole cellular copy of Nab2 (36).
###end p 11
###begin p 12
###xml 164 177 164 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae</italic>
###xml 365 367 365 367 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 674 676 674 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref43">43</xref>
###xml 874 876 874 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref45">45</xref>
###xml 1072 1074 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1076 1078 1076 1078 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref46">46</xref>
###xml 1193 1195 1193 1195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1444 1446 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref39">39</xref>
###xml 1459 1463 1459 1463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLP1</italic>
###xml 1468 1472 1468 1472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLP2</italic>
###xml 1520 1524 1520 1524 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlp1</italic>
###xml 1533 1537 1529 1533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlp2</italic>
###xml 1570 1574 1562 1566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlp1</italic>
###xml 1580 1584 1568 1572 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mlp2</italic>
###xml 1665 1667 1649 1651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref41">41</xref>
###xml 1669 1671 1653 1655 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref47">47</xref>
###xml 1673 1675 1657 1659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref48">48</xref>
###xml 1699 1703 1683 1687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLP1</italic>
###xml 1888 1890 1872 1874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref40">40</xref>
###xml 164 177 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1018 1023 <span type="species:ncbi:9606">human</span>
###xml 1453 1458 <span type="species:ncbi:4932">yeast</span>
For efficient transport of mRNA, export adaptors and hnRNPs may contribute to mRNA export through facilitating interactions with components of the nuclear pore. In S. cerevisiae, the nuclear pore-associated protein, myosin-like protein 1 (Mlp1), acts as a docking platform for hnRNPs and other mRNA factors and also plays a role in mRNA export and quality control (38-40). Mlp1 and its close relative Mlp2 are large proteins attached to the nucleoplasmic face of the nuclear pore that are homologous to the mammalian Tpr (translocated promoter region) protein and are thought to act like control gates at the NPC portal to grant or deny mRNA access to the cytoplasm (38, 40-43). The Mlp1/2/Tpr proteins contain a coiled-coil N-terminal domain that tethers them to the pore via specific nucleoporins and a globular C-terminal domain that binds to mRNA export factors (38, 43-45). Notably, the C-terminal domain of Mlp1 (CT-Mlp1) binds to the hnRNPs, Nab2 and Npl3, and expression of CT-Mlp1 or the C-terminal domain of human Tpr causes nuclear accumulation of poly(A) RNA (38, 46), linking the Mlp1/Tpr proteins with mRNA export. The Mlp1/2 proteins also bind to the mRNA export adaptor, Yra1 (39). Significantly, Mlp2 binds more strongly to the Yra1-8 export mutant protein than to wild-type Yra1, suggesting that Mlp2 recruits Yra1 for docking of mRNA-protein complexes, but retains malformed complexes that contain the Yra1-8 mutant protein (39). The yeast MLP1 and MLP2 genes are not essential for cell viability and mlp1Delta or mlp2Delta single deletion mutants or mlp1Delta mlp2Delta double deletion mutants are viable and show no significant growth defects (41, 47, 48). However, deletion of MLP1 impairs nuclear retention of intron-containing mRNAs and permits the escape of pre-mRNA to the cytoplasm, supporting the notion that Mlp1 plays a pivotal role in mRNA quality control (40).
###end p 12
###begin p 13
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 288 290 284 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 292 294 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 401 403 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref50">50</xref>
###xml 455 457 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 533 535 529 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 615 617 611 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 663 665 659 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 783 785 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 787 789 783 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
The N-terminal domain of Nab2 (Nab2-N) is both necessary and sufficient to bind to Mlp1 (49). Structural studies show that this domain has a fold based on a five alpha-helix bundle analogous to the proline-tryptophan-isoleucine (PWI) fold, which is found in several RNA-binding proteins (49, 50). Although the PWI fold is thought to mediate binding to RNA and DNA in other RNA-binding proteins acids (50), Nab2-N does not appear to bind to nucleic acids (49). The Nab2-N structure revealed a hydrophobic patch centered on residue Phe73 that could potentially serve as an interface for protein-protein interactions (49). Previously, we showed that Nab2 residue Phe73 is important for the interaction between Nab2 and Mlp1, but not between Nab2 and Gfd1, another Nab2-binding partner (49, 51).
###end p 13
###begin p 14
###xml 656 663 656 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 696 703 696 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Given the way in which Nab2 and Mlp1 function in mRNA export and quality control, we have investigated the interaction between these two proteins in greater detail and show here that the Nab2-binding domain of Mlp1 (Mlp1-NBD) maps to a 183-amino acid region (residues 1586-1768) within CT-Mlp1. The Mlp1-NBD can bind directly to Nab2 and expression of this domain is sufficient to cause nuclear accumulation of poly(A) RNA, confirming the tight link between Nab2, CT-Mlp1, and poly(A) RNA. We then use a structure-based engineered mutant of Nab2 that cannot interact with Mlp1 to explore the functional consequences of disrupting the Nab2/Mlp1 interaction in vivo. Overall, these studies provide in vivo evidence for a model of mRNA export in which Nab2 is important for targeting mRNAs to the nuclear pore for export.
###end p 14
###begin title 15
EXPERIMENTAL PROCEDURES
###end title 15
###begin p 16
###xml 0 32 0 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Plasmids, Strains, and Chemicals</italic>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref52">52</xref>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref53">53</xref>
###xml 211 218 211 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl1">Table 1</xref>
###xml 162 167 <span type="species:ncbi:4932">Yeast</span>
Plasmids, Strains, and Chemicals-All DNA manipulations were performed according to standard methods (52) and all media were prepared by standard procedures (53). Yeast strains and plasmids used are described in Table 1. All chemicals were obtained from Sigma, U. S. Biological Corp. (Swampscott, MA), or Fisher Scientific (Pittsburgh, PA) unless otherwise noted.
###end p 16
###begin p 17
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 1</label>
###xml 7 33 7 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Yeast strains and plasmids</bold>
###xml 7 33 7 33 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="18"><bold>Yeast strains and plasmids</bold></p>
###xml 7 33 7 33 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="18"><bold>Yeast strains and plasmids</bold></p></caption>
###xml 33 47 33 47 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Strain/plasmid</bold>
###xml 33 47 33 47 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Strain/plasmid</bold></th>
###xml 47 58 47 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Description</bold>
###xml 47 58 47 58 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Description</bold></th>
###xml 58 72 58 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Source or Ref.</bold>
###xml 58 72 58 72 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Source or Ref.</bold></th>
###xml 33 72 33 72 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Strain/plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Source or Ref.</bold></th></tr>
###xml 33 72 33 72 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Strain/plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Source or Ref.</bold></th></tr></thead>
###xml 72 87 72 87 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> W303 (ACY233) </td>
###xml 87 135 87 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic>
###xml 87 135 87 115 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic></td>
###xml 135 135 115 115 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 72 135 72 115 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> W303 (ACY233) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr>
###xml 135 144 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2&#916;</italic>
###xml 135 154 115 130 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;</italic> (ACY427) </td>
###xml 154 199 130 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic>
###xml 154 209 130 173 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic> (pAC636) </td>
###xml 209 211 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref72">72</xref>
###xml 209 211 173 175 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref72">72</xref></td>
###xml 135 211 115 175 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;</italic> (ACY427) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic> (pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref72">72</xref></td></tr>
###xml 211 230 175 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2&#916;MEX67&#916;</italic>
###xml 211 241 175 197 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;MEX67&#916;</italic> (SWY3601) </td>
###xml 257 308 209 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic>
###xml 317 324 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 241 326 197 266 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> MATa trp1&#916; <italic>leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic> (pRS314-<italic>mex67-5</italic>) </td>
###xml 326 328 266 268 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref70">70</xref>
###xml 326 328 266 268 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref70">70</xref></td>
###xml 211 328 175 268 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;MEX67&#916;</italic> (SWY3601) </td><td colspan="1" rowspan="1" align="center" valign="top"> MATa trp1&#916; <italic>leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic> (pRS314-<italic>mex67-5</italic>) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref70">70</xref></td></tr>
###xml 328 346 268 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2&#916;YRA1&#916;</italic>
###xml 328 357 268 289 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;YRA1&#916;</italic> (FSY2327) </td>
###xml 357 423 289 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic>
###xml 357 442 289 358 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic> (pFS1876, pAC636) </td>
###xml 442 452 358 368 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> F. Stutz </td>
###xml 328 452 268 368 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;YRA1&#916;</italic> (FSY2327) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic> (pFS1876, pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"> F. Stutz </td></tr>
###xml 452 462 368 378 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-3 </td>
###xml 470 471 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 462 472 378 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST, AMP<sub>R</sub>,</italic>
###xml 462 501 378 417 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub>,</italic> bacterial expression vector </td>
###xml 501 516 417 432 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td>
###xml 452 516 368 432 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-3 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr>
###xml 516 525 432 441 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1340 </td>
###xml 525 536 441 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT-Mlp1</italic>
###xml 574 575 490 491 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 561 575 477 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 525 575 441 491 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT-Mlp1</italic> (residues 1490&#8211;1875) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 575 577 491 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 575 577 491 493 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref38">38</xref></td>
###xml 516 577 432 493 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1340 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT-Mlp1</italic> (residues 1490&#8211;1875) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref38">38</xref></td></tr>
###xml 577 586 493 502 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1678 </td>
###xml 586 593 502 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT5</italic>
###xml 631 632 547 548 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 618 632 534 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 586 632 502 548 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT5</italic> (residues 1490&#8211;1585) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 632 644 548 560 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 577 644 493 560 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1678 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT5</italic> (residues 1490&#8211;1585) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 644 653 560 569 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1679 </td>
###xml 653 660 569 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT4</italic>
###xml 698 699 614 615 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 685 699 601 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 653 699 569 615 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT4</italic> (residues 1490&#8211;1682) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 699 711 615 627 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 644 711 560 627 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1679 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT4</italic> (residues 1490&#8211;1682) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 711 720 627 636 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1680 </td>
###xml 720 727 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT2</italic>
###xml 765 766 681 682 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 752 766 668 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 720 766 636 682 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT2</italic> (residues 1490&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 766 778 682 694 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 711 778 627 694 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1680 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT2</italic> (residues 1490&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 778 787 694 703 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1681 </td>
###xml 787 794 703 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT6</italic>
###xml 832 833 748 749 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 819 833 735 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 787 833 703 749 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT6</italic> (residues 1586&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 833 845 749 761 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 778 845 694 761 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1681 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT6</italic> (residues 1586&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 845 854 761 770 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1723 </td>
###xml 854 861 770 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-CT7</italic>
###xml 899 900 815 816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 886 900 802 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-3, AMP<sub>R</sub></italic>
###xml 854 900 770 816 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT7</italic> (residues 1677&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td>
###xml 900 912 816 828 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 845 912 761 828 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1723 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT7</italic> (residues 1677&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 912 922 828 838 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-1 </td>
###xml 930 931 846 847 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 922 931 838 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST, AMP<sub>R</sub></italic>
###xml 922 961 838 877 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub></italic>, bacterial expression vector </td>
###xml 961 976 877 892 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td>
###xml 912 976 828 892 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-1 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub></italic>, bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr>
###xml 976 985 892 901 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2058 </td>
###xml 985 998 901 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-Nab2-N-WT</italic>
###xml 1031 1032 947 948 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1018 1032 934 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-1, AMP<sub>R</sub></italic>
###xml 985 1032 901 948 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td>
###xml 1032 1034 948 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1032 1034 948 950 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td>
###xml 976 1034 892 950 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2058 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr>
###xml 1034 1043 950 959 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2349 </td>
###xml 1043 1058 959 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-Nab2-N-F72D</italic>
###xml 1091 1092 1007 1008 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1078 1092 994 1008 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-1, AMP<sub>R</sub></italic>
###xml 1043 1092 959 1008 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F72D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td>
###xml 1092 1094 1008 1010 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1092 1094 1008 1010 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td>
###xml 1034 1094 950 1010 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2349 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F72D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr>
###xml 1094 1103 1010 1019 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2350 </td>
###xml 1103 1118 1019 1034 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-Nab2-N-F73D</italic>
###xml 1151 1152 1067 1068 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1138 1152 1054 1068 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-1, AMP<sub>R</sub></italic>
###xml 1103 1152 1019 1068 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td>
###xml 1152 1154 1068 1070 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1152 1154 1068 1070 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td>
###xml 1094 1154 1010 1070 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2350 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr>
###xml 1154 1163 1070 1079 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2453 </td>
###xml 1163 1178 1079 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GST-Nab2-N-F73W</italic>
###xml 1211 1212 1127 1128 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1198 1212 1114 1128 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGEX4T-1, AMP<sub>R</sub></italic>
###xml 1163 1212 1079 1128 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73W</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td>
###xml 1212 1214 1128 1130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1212 1214 1128 1130 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td>
###xml 1154 1214 1070 1130 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2453 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73W</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr>
###xml 1214 1222 1130 1138 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pET28a </td>
###xml 1225 1226 1141 1142 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1231 1232 1147 1148 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1222 1233 1138 1149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His<sub>6</sub>, KAN<sub>R</sub>,</italic>
###xml 1222 1262 1138 1178 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, KAN<sub>R</sub>,</italic> bacterial expression vector </td>
###xml 1262 1271 1178 1187 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Novagen </td>
###xml 1214 1271 1130 1187 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pET28a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr>
###xml 1271 1279 1187 1195 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC785 </td>
###xml 1282 1283 1198 1199 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1279 1288 1195 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His<sub>6</sub>-Nab2</italic>
###xml 1303 1304 1219 1220 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1292 1304 1208 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pET28a, KAN<sub>R</sub></italic>
###xml 1279 1304 1195 1220 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2</italic> in <italic>pET28a, KAN<sub>R</sub></italic></td>
###xml 1304 1306 1220 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 1304 1306 1220 1222 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td>
###xml 1271 1306 1187 1222 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC785 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2</italic> in <italic>pET28a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr>
###xml 1306 1314 1222 1230 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pET30a </td>
###xml 1317 1318 1233 1234 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1330 1331 1246 1247 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1314 1332 1230 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic>
###xml 1314 1361 1230 1277 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic> bacterial expression vector </td>
###xml 1361 1370 1277 1286 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Novagen </td>
###xml 1306 1370 1222 1286 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pET30a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr>
###xml 1370 1379 1286 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2052 </td>
###xml 1382 1383 1298 1299 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1379 1393 1295 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His<sub>6</sub>-Nab2-N-WT</italic>
###xml 1424 1425 1340 1341 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1413 1425 1329 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pET30a, KAN<sub>R</sub></italic>
###xml 1379 1425 1295 1341 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pET30a, KAN<sub>R</sub></italic></td>
###xml 1425 1437 1341 1353 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1370 1437 1286 1353 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2052 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1437 1446 1353 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2054 </td>
###xml 1449 1450 1365 1366 <sub xmlns:xlink="http://www.w3.org/1999/xlink">6</sub>
###xml 1446 1465 1362 1381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">His<sub>6</sub>-S-Tag-Mlp1-NBD</italic>
###xml 1501 1502 1417 1418 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1490 1502 1406 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pET30a, KAN<sub>R</sub></italic>
###xml 1446 1502 1362 1418 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-S-Tag-Mlp1-NBD</italic> (residues 1586&#8211;1768) in <italic>pET30a, KAN<sub>R</sub></italic></td>
###xml 1502 1514 1418 1430 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1437 1514 1353 1430 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2054 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-S-Tag-Mlp1-NBD</italic> (residues 1586&#8211;1768) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1514 1530 1430 1446 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pPS295 (pAC18) </td>
###xml 1530 1546 1446 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1, 2&#956;, URA3</italic>
###xml 1530 1546 1446 1461 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1, 2&#956;, URA3</italic></td>
###xml 1546 1548 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref73">73</xref>
###xml 1546 1548 1461 1463 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref73">73</xref></td>
###xml 1514 1548 1430 1463 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pPS295 (pAC18) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1, 2&#956;, URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref73">73</xref></td></tr>
###xml 1548 1557 1463 1472 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2075 </td>
###xml 1557 1567 1472 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40</italic>
###xml 1578 1590 1493 1505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NLS-MLP1-NBD</italic>
###xml 1627 1628 1541 1542 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1618 1628 1532 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 1557 1628 1472 1542 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-MLP1-NBD</italic> (residues 1586&#8211;1768), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 1628 1640 1542 1554 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1548 1640 1463 1554 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2075 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-MLP1-NBD</italic> (residues 1586&#8211;1768), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1640 1649 1554 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1690 </td>
###xml 1649 1659 1563 1573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40</italic>
###xml 1670 1685 1584 1599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NLS-myc-CT-MLP1</italic>
###xml 1722 1723 1635 1636 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1713 1723 1626 1636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 1649 1723 1563 1636 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT-MLP1</italic> (residues 1490&#8211;1875), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 1723 1735 1636 1648 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1640 1735 1554 1648 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1690 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT-MLP1</italic> (residues 1490&#8211;1875), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1735 1744 1648 1657 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1692 </td>
###xml 1744 1754 1657 1667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40</italic>
###xml 1765 1776 1678 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NLS-myc-CT5</italic>
###xml 1813 1814 1725 1726 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1804 1814 1716 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 1744 1814 1657 1726 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT5</italic> (residues 1490&#8211;1585), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 1814 1826 1726 1738 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1735 1826 1648 1738 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1692 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT5</italic> (residues 1490&#8211;1585), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1826 1835 1738 1747 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1693 </td>
###xml 1835 1845 1747 1757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40</italic>
###xml 1856 1867 1768 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NLS-myc-CT4</italic>
###xml 1904 1905 1815 1816 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1895 1905 1806 1816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 1835 1905 1747 1816 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT4</italic> (residues 1490&#8211;1682), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 1905 1917 1816 1828 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1826 1917 1738 1828 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1693 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT4</italic> (residues 1490&#8211;1682), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 1917 1926 1828 1837 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1694 </td>
###xml 1926 1958 1837 1869 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40 bipartite NLS-myc-CT3</italic>
###xml 1995 1996 1905 1906 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 1986 1996 1896 1906 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 1926 1996 1837 1906 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT3</italic> (residues 1490&#8211;1717), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 1996 2008 1906 1918 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 1917 2008 1828 1918 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1694 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT3</italic> (residues 1490&#8211;1717), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 2008 2017 1918 1927 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1695 </td>
###xml 2017 2049 1927 1959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40 bipartite NLS-myc-CT2</italic>
###xml 2086 2087 1995 1996 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2077 2087 1986 1996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 2017 2087 1927 1996 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT2</italic> (residues 1490&#8211;1779), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 2087 2099 1996 2008 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 2008 2099 1918 2008 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1695 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT2</italic> (residues 1490&#8211;1779), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 2099 2108 2008 2017 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1696 </td>
###xml 2108 2118 2017 2027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pGAL1-SV40</italic>
###xml 2129 2140 2038 2049 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NLS-myc-CT1</italic>
###xml 2177 2178 2085 2086 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2168 2178 2076 2086 <italic xmlns:xlink="http://www.w3.org/1999/xlink">URA3, AMP<sub>R</sub></italic>
###xml 2108 2178 2017 2086 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT1</italic> (residues 1490&#8211;1811), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td>
###xml 2178 2190 2086 2098 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 2099 2190 2008 2098 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1696 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT1</italic> (residues 1490&#8211;1811), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 2190 2198 2098 2106 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC636 </td>
###xml 2218 2219 2126 2127 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2198 2219 2106 2127 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, CEN, URA3, AMP<sub>R</sub></italic>
###xml 2198 2219 2106 2127 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, URA3, AMP<sub>R</sub></italic></td>
###xml 2219 2221 2127 2129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 2219 2221 2127 2129 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td>
###xml 2190 2221 2098 2129 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC636 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr>
###xml 2221 2229 2129 2137 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC717 </td>
###xml 2249 2250 2157 2158 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2229 2250 2137 2158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, CEN, LEU2, AMP<sub>R</sub></italic>
###xml 2229 2250 2137 2158 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, LEU2, AMP<sub>R</sub></italic></td>
###xml 2250 2252 2158 2160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 2250 2252 2158 2160 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td>
###xml 2221 2252 2129 2160 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC717 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr>
###xml 2252 2261 2160 2169 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1152 </td>
###xml 2288 2289 2192 2193 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2261 2289 2169 2193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic>
###xml 2261 2289 2169 2193 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic></td>
###xml 2289 2291 2193 2195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 2289 2291 2193 2195 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td>
###xml 2252 2291 2160 2195 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1152 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr>
###xml 2291 2300 2195 2204 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2351 </td>
###xml 2325 2326 2229 2230 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2300 2326 2204 2230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic>
###xml 2300 2326 2204 2230 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic></td>
###xml 2326 2338 2230 2242 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 2291 2338 2195 2242 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2351 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 2338 2347 2242 2251 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC2352 </td>
###xml 2372 2373 2276 2277 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2347 2373 2251 2277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic>
###xml 2347 2373 2251 2277 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic></td>
###xml 2373 2385 2277 2289 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> This study </td>
###xml 2338 2385 2242 2289 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC2352 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr>
###xml 2385 2394 2289 2298 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pAC1036 </td>
###xml 2427 2428 2327 2328 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2394 2428 2298 2328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic>
###xml 2394 2428 2298 2328 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic></td>
###xml 2428 2430 2328 2330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 2428 2430 2328 2330 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td>
###xml 2385 2430 2289 2330 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pAC1036 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr>
###xml 2430 2439 2330 2339 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pFS1876 </td>
###xml 2459 2460 2359 2360 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2439 2460 2339 2360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YRA1, CEN, URA3, AMP<sub>R</sub></italic>
###xml 2439 2460 2339 2360 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>YRA1, CEN, URA3, AMP<sub>R</sub></italic></td>
###xml 2460 2462 2360 2362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 2460 2462 2360 2362 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref19">19</xref></td>
###xml 2430 2462 2330 2362 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pFS1876 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>YRA1, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref19">19</xref></td></tr>
###xml 2462 2481 2362 2381 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pFS2152 (pAC2266) </td>
###xml 2503 2504 2403 2404 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2481 2504 2381 2404 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic>
###xml 2481 2504 2381 2404 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic></td>
###xml 2504 2506 2404 2406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 2504 2506 2404 2406 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref21">21</xref></td>
###xml 2462 2506 2362 2406 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pFS2152 (pAC2266) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref21">21</xref></td></tr>
###xml 2514 2521 2414 2421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 2506 2521 2406 2421 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> pRS314-<italic>mex67-5</italic></td>
###xml 2544 2545 2444 2445 <sub xmlns:xlink="http://www.w3.org/1999/xlink">R</sub>
###xml 2521 2545 2421 2445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5, CEN, TRP1, AMP<sub>R</sub></italic>
###xml 2521 2545 2421 2445 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><italic>mex67-5, CEN, TRP1, AMP<sub>R</sub></italic></td>
###xml 2545 2546 2445 2446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 2545 2546 2445 2446 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref8">8</xref></td>
###xml 2506 2546 2406 2446 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> pRS314-<italic>mex67-5</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>mex67-5, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref8">8</xref></td></tr>
###xml 72 2546 72 2446 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"> W303 (ACY233) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;</italic> (ACY427) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic> (pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref72">72</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;MEX67&#916;</italic> (SWY3601) </td><td colspan="1" rowspan="1" align="center" valign="top"> MATa trp1&#916; <italic>leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic> (pRS314-<italic>mex67-5</italic>) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref70">70</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;YRA1&#916;</italic> (FSY2327) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic> (pFS1876, pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"> F. Stutz </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-3 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1340 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT-Mlp1</italic> (residues 1490&#8211;1875) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref38">38</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1678 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT5</italic> (residues 1490&#8211;1585) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1679 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT4</italic> (residues 1490&#8211;1682) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1680 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT2</italic> (residues 1490&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1681 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT6</italic> (residues 1586&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1723 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT7</italic> (residues 1677&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-1 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub></italic>, bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2058 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2349 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F72D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2350 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2453 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73W</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET28a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC785 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2</italic> in <italic>pET28a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET30a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2052 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2054 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-S-Tag-Mlp1-NBD</italic> (residues 1586&#8211;1768) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pPS295 (pAC18) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1, 2&#956;, URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref73">73</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2075 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-MLP1-NBD</italic> (residues 1586&#8211;1768), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1690 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT-MLP1</italic> (residues 1490&#8211;1875), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1692 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT5</italic> (residues 1490&#8211;1585), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1693 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT4</italic> (residues 1490&#8211;1682), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1694 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT3</italic> (residues 1490&#8211;1717), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1695 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT2</italic> (residues 1490&#8211;1779), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1696 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT1</italic> (residues 1490&#8211;1811), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC636 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC717 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1152 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2351 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2352 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1036 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS1876 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>YRA1, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref19">19</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS2152 (pAC2266) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref21">21</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pRS314-<italic>mex67-5</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>mex67-5, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref8">8</xref></td></tr></tbody>
###xml 33 2546 33 2446 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Strain/plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Source or Ref.</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> W303 (ACY233) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;</italic> (ACY427) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic> (pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref72">72</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;MEX67&#916;</italic> (SWY3601) </td><td colspan="1" rowspan="1" align="center" valign="top"> MATa trp1&#916; <italic>leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic> (pRS314-<italic>mex67-5</italic>) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref70">70</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;YRA1&#916;</italic> (FSY2327) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic> (pFS1876, pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"> F. Stutz </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-3 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1340 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT-Mlp1</italic> (residues 1490&#8211;1875) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref38">38</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1678 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT5</italic> (residues 1490&#8211;1585) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1679 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT4</italic> (residues 1490&#8211;1682) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1680 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT2</italic> (residues 1490&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1681 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT6</italic> (residues 1586&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1723 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT7</italic> (residues 1677&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-1 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub></italic>, bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2058 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2349 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F72D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2350 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2453 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73W</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET28a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC785 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2</italic> in <italic>pET28a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET30a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2052 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2054 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-S-Tag-Mlp1-NBD</italic> (residues 1586&#8211;1768) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pPS295 (pAC18) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1, 2&#956;, URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref73">73</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2075 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-MLP1-NBD</italic> (residues 1586&#8211;1768), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1690 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT-MLP1</italic> (residues 1490&#8211;1875), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1692 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT5</italic> (residues 1490&#8211;1585), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1693 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT4</italic> (residues 1490&#8211;1682), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1694 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT3</italic> (residues 1490&#8211;1717), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1695 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT2</italic> (residues 1490&#8211;1779), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1696 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT1</italic> (residues 1490&#8211;1811), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC636 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC717 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1152 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2351 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2352 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1036 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS1876 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>YRA1, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref19">19</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS2152 (pAC2266) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref21">21</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pRS314-<italic>mex67-5</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>mex67-5, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref8">8</xref></td></tr></tbody></table>
###xml 0 2546 0 2446 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl1"><label>TABLE 1</label><caption><p textid="18"><bold>Yeast strains and plasmids</bold></p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Strain/plasmid</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Description</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Source or Ref.</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"> W303 (ACY233) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MAT&#945; ura3&#916; leu2&#916; trp1&#916; his3&#916;</italic></td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;</italic> (ACY427) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa leu2&#916; ura3&#916; his3&#916; NAB2::HIS3</italic> (pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref72">72</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;MEX67&#916;</italic> (SWY3601) </td><td colspan="1" rowspan="1" align="center" valign="top"> MATa trp1&#916; <italic>leu2&#916; his3&#916; ura3&#916; NAB2::HIS3 MEX67::KAN</italic> (pRS314-<italic>mex67-5</italic>) </td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref70">70</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>NAB2&#916;YRA1&#916;</italic> (FSY2327) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>MATa ura3&#916; his3&#916; leu2&#916; trp1&#916; YRA1::HIS3 NAB2::HIS3</italic> (pFS1876, pAC636) </td><td colspan="1" rowspan="1" align="center" valign="top"> F. Stutz </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-3 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1340 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT-Mlp1</italic> (residues 1490&#8211;1875) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref38">38</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1678 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT5</italic> (residues 1490&#8211;1585) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1679 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT4</italic> (residues 1490&#8211;1682) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1680 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT2</italic> (residues 1490&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1681 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT6</italic> (residues 1586&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1723 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-CT7</italic> (residues 1677&#8211;1779) in <italic>pGEX4T-3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pGEX4T-1 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST, AMP<sub>R</sub></italic>, bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> GE Healthcare </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2058 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2349 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F72D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2350 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73D</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2453 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>GST-Nab2-N-F73W</italic> (residues 1&#8211;97) in <italic>pGEX4T-1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref49">49</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET28a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC785 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2</italic> in <italic>pET28a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pET30a </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>, S-Tag, KAN<sub>R</sub>,</italic> bacterial expression vector </td><td colspan="1" rowspan="1" align="center" valign="top"> Novagen </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2052 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-Nab2-N-WT</italic> (residues 1&#8211;97) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2054 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>His<sub>6</sub>-S-Tag-Mlp1-NBD</italic> (residues 1586&#8211;1768) in <italic>pET30a, KAN<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pPS295 (pAC18) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1, 2&#956;, URA3</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref73">73</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2075 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-MLP1-NBD</italic> (residues 1586&#8211;1768), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1690 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT-MLP1</italic> (residues 1490&#8211;1875), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1692 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT5</italic> (residues 1490&#8211;1585), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1693 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT4</italic> (residues 1490&#8211;1682), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1694 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT3</italic> (residues 1490&#8211;1717), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1695 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40 bipartite NLS-myc-CT2</italic> (residues 1490&#8211;1779), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1696 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>pGAL1-SV40</italic> bipartite <italic>NLS-myc-CT1</italic> (residues 1490&#8211;1811), 2&#956;, <italic>URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC636 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref32">32</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC717 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>NAB2, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1152 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 &#916;N, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2351 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F72D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC2352 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>nab2 F73D, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"> This study </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pAC1036 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>&#916;RGG NAB2-GFP, CEN, LEU2, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref36">36</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS1876 </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>YRA1, CEN, URA3, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref19">19</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pFS2152 (pAC2266) </td><td colspan="1" rowspan="1" align="center" valign="top"><italic>yra1&#8211;8, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref21">21</xref></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> pRS314-<italic>mex67-5</italic></td><td colspan="1" rowspan="1" align="center" valign="top"><italic>mex67-5, CEN, TRP1, AMP<sub>R</sub></italic></td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="bibr" rid="ref8">8</xref></td></tr></tbody></table></table-wrap>
###xml 1563 1567 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1655 1659 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1750 1754 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1841 1845 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1932 1936 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 2023 2027 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 2114 2118 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
TABLE 1Yeast strains and plasmidsStrain/plasmidDescriptionSource or Ref. W303 (ACY233) MATalpha ura3Delta leu2Delta trp1Delta his3DeltaNAB2Delta (ACY427) MATa leu2Delta ura3Delta his3Delta NAB2::HIS3 (pAC636) 72NAB2DeltaMEX67Delta (SWY3601)  MATa trp1Delta leu2Delta his3Delta ura3Delta NAB2::HIS3 MEX67::KAN (pRS314-mex67-5) 70NAB2DeltaYRA1Delta (FSY2327) MATa ura3Delta his3Delta leu2Delta trp1Delta YRA1::HIS3 NAB2::HIS3 (pFS1876, pAC636)  F. Stutz  pGEX4T-3 GST, AMPR, bacterial expression vector  GE Healthcare  pAC1340 GST-CT-Mlp1 (residues 1490-1875) in pGEX4T-3, AMPR38 pAC1678 GST-CT5 (residues 1490-1585) in pGEX4T-3, AMPR This study  pAC1679 GST-CT4 (residues 1490-1682) in pGEX4T-3, AMPR This study  pAC1680 GST-CT2 (residues 1490-1779) in pGEX4T-3, AMPR This study  pAC1681 GST-CT6 (residues 1586-1779) in pGEX4T-3, AMPR This study  pAC1723 GST-CT7 (residues 1677-1779) in pGEX4T-3, AMPR This study  pGEX4T-1 GST, AMPR, bacterial expression vector  GE Healthcare  pAC2058 GST-Nab2-N-WT (residues 1-97) in pGEX4T-1, AMPR49 pAC2349 GST-Nab2-N-F72D (residues 1-97) in pGEX4T-1, AMPR49 pAC2350 GST-Nab2-N-F73D (residues 1-97) in pGEX4T-1, AMPR49 pAC2453 GST-Nab2-N-F73W (residues 1-97) in pGEX4T-1, AMPR49 pET28a His6, KANR, bacterial expression vector  Novagen  pAC785 His6-Nab2 in pET28a, KANR32 pET30a His6, S-Tag, KANR, bacterial expression vector  Novagen  pAC2052 His6-Nab2-N-WT (residues 1-97) in pET30a, KANR This study  pAC2054 His6-S-Tag-Mlp1-NBD (residues 1586-1768) in pET30a, KANR This study  pPS295 (pAC18) pGAL1, 2mu, URA373 pAC2075 pGAL1-SV40 bipartite NLS-MLP1-NBD (residues 1586-1768), 2mu, URA3, AMPR This study  pAC1690 pGAL1-SV40 bipartite NLS-myc-CT-MLP1 (residues 1490-1875), 2mu, URA3, AMPR This study  pAC1692 pGAL1-SV40 bipartite NLS-myc-CT5 (residues 1490-1585), 2mu, URA3, AMPR This study  pAC1693 pGAL1-SV40 bipartite NLS-myc-CT4 (residues 1490-1682), 2mu, URA3, AMPR This study  pAC1694 pGAL1-SV40 bipartite NLS-myc-CT3 (residues 1490-1717), 2mu, URA3, AMPR This study  pAC1695 pGAL1-SV40 bipartite NLS-myc-CT2 (residues 1490-1779), 2mu, URA3, AMPR This study  pAC1696 pGAL1-SV40 bipartite NLS-myc-CT1 (residues 1490-1811), 2mu, URA3, AMPR This study  pAC636 NAB2, CEN, URA3, AMPR32 pAC717 NAB2, CEN, LEU2, AMPR36 pAC1152 nab2 DeltaN, CEN, LEU2, AMPR36 pAC2351 nab2 F72D, CEN, LEU2, AMPR This study  pAC2352 nab2 F73D, CEN, LEU2, AMPR This study  pAC1036 DeltaRGG NAB2-GFP, CEN, LEU2, AMPR36 pFS1876 YRA1, CEN, URA3, AMPR19 pFS2152 (pAC2266) yra1-8, CEN, TRP1, AMPR21 pRS314-mex67-5mex67-5, CEN, TRP1, AMPR8
###end p 17
###begin p 18
###xml 0 26 0 26 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Yeast strains and plasmids</bold>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and plasmids
###end p 18
###begin p 19
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Generation of Nab2 Mutants</italic>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 157 166 157 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 181 190 181 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
Generation of Nab2 Mutants-Nab2 mutants GST-NT F72D (pAC2349), GST-NT F73D (pAC2350), and GST-NT-F73W (pAC2453) were previously described (49). Nab2 mutants nab2 F72D (pAC2351) and nab2 F73D (pAC2352) were generated by site-directed mutagenesis using oligonucleotides (Integrated DNA Technologies) encoding the F72D or F73D amino acid substitution, NAB2 (pAC717) plasmid template, and QuikChange Site-directed Mutagenesis Kit (Stratagene). All constructs were sequenced to ensure the presence of each desired mutation and the absence of any additional mutations.
###end p 19
###begin p 20
###xml 0 35 0 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Protein Expression and Purification</italic>
###xml 127 135 127 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 351 367 351 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 612 619 612 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 860 861 854 855 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 861 864 855 858 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 896 897 889 890 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 915 916 908 909 <sc xmlns:xlink="http://www.w3.org/1999/xlink">d</sc>
###xml 1141 1142 1128 1129 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1684 1685 1665 1666 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1941 1942 1922 1923 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1966 1967 1947 1948 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2070 2071 2051 2052 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2201 2202 2182 2183 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2206 2207 2187 2188 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2209 2210 2190 2191 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2225 2226 2206 2207 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2237 2238 2218 2219 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2558 2559 2533 2534 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2563 2564 2538 2539 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2566 2567 2541 2542 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2582 2583 2557 2558 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2594 2595 2569 2570 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2686 2687 2661 2662 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2691 2692 2666 2667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2694 2695 2669 2670 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2710 2711 2685 2686 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2723 2724 2698 2699 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2787 2788 2762 2763 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2973 2974 2948 2949 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 2978 2979 2953 2954 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 2981 2982 2956 2957 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 2997 2998 2972 2973 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3009 3010 2984 2985 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3025 3026 3000 3001 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3283 3284 3258 3259 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3288 3289 3263 3264 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 3291 3292 3266 3267 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 3307 3308 3282 3283 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3320 3321 3295 3296 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3336 3337 3311 3312 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 3445 3446 3420 3421 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 351 367 <span type="species:ncbi:562">Escherichia coli</span>
###xml 612 619 <span type="species:ncbi:562">E. coli</span>
Protein Expression and Purification-Recombinant GST fusion and His-tagged proteins were expressed in bacteria and purified for in vitro solution and solid phase binding assays. GST (pGEX4T-3), GST-CT-Mlp1 (pAC1340), GST-CT2 (pAC1680), GST-CT4 (pAC1679), GST-CT5 (pAC1678), GST-CT6 (pAC1681), GST-CT7 (pAC1723), and His-Nab2 (pAC785) were expressed in Escherichia coli DE3 cells and purified by batch purification. GST (pGEX4T-1), GST-Nab2-N-WT (pAC2058), GST-Nab2-N-F72D (pAC2349), GST-Nab2-N-F73D (pAC2350), GST-Nab2-N-F73W (pAC2453), His-Nab2-N-WT (pAC2052), and His-S-Tag-Mlp1-NBD (pAC2054) were expressed in E. coli DE3 cells and purified by column chromatography. Overnight cultures were used to inoculate 100 ml of LB media for batch purification or 1 liter of LB media for purification by column chromatography. Cultures were grown at 37 degreesC to an A600 of 0.6-0.8, induced with 200 mum isopropyl 1-thio-d-galactopyranoside, and grown at 30 degreesC for 5 h. For batch purification of GST fusion proteins, cells were collected and lysed in 10 ml of phosphate-buffered saline (PBS) supplemented with protease inhibitor mixture (1 mm phenylmethylsulfonyl fluoride, 3 ng/ml pepstatin A, leupeptin, aproptinin, and chymostatin) by incubation with lysozyme (100 mg/ml) for 30 min on ice and sonication. Lysates were cleared by centrifugation and incubated with glutathione-Sepharose 4B (GE Healthcare) for 2 h at 4degreesC with mixing. The beads were then washed once with 10 ml of PBS supplemented with 0.5% Triton X-100 and twice with 10 ml of PBS. For purification of GST fusion proteins by column chromatography, cells were collected and lysed in 20 ml of buffer A (PBS, 2 mm 2-mercaptoethanol) supplemented with protease inhibitor mixture by a French press and cleared lysates were loaded onto a GSTrap 4B column (GE Healthcare) pre-equilibrated with buffer A. Bound protein was eluted with a linear gradient of buffer B (PBS, 2 mm 2-mercaptoethanol, 10 mm reduced glutathione) and fractions containing GST protein were dialyzed into PBS supplemented with 2 mm dithiothreitol (DTT). For batch purification of Histagged proteins, cells were collected and lysed in 10 ml of lysis buffer (50 mm NaH2PO4, pH 7.4, 300 mm NaCl, 10 mm imidazole) supplemented with protease inhibitor mixture by incubation with lysozyme and sonication. Lysates were cleared by centrifugation and incubated with nickel-nitrilotriacetic acid-agarose (Qiagen) in lysis buffer for 2 h at 4 degreesC with mixing. The beads were then washed twice with 10 ml of wash buffer (50 mm NaH2PO4, pH 7.4, 300 mm NaCl, 20 mm imidazole). His-tagged proteins were eluted from agarose with 1 ml of elution buffer (50 mm NaH2PO4, pH 7.4, 300 mm NaCl, 250 mm imidazole) and buffer exchanged into PBS supplemented with 2 mm DTT using a Centricon centrifugal filter device (Millipore). For purification of His-tagged proteins by column chromatography, cells were collected and lysed in 20 ml of buffer A (50 mm NaH2PO4, pH 7.4, 500 mm NaCl, 20 mm imidazole, 2 mm 2-mercaptoethanol) supplemented with protease inhibitor mixture by a French press and cleared lysates were loaded onto a HiTrap IMAC HP column (GE Healthcare) pre-equilibrated with buffer A. Bound protein was eluted with a linear gradient of buffer B (50 mm NaH2PO4, pH 7.4, 300 mm NaCl, 250 mm imidazole, 2 mm 2-mercaptoethanol) and fractions containing His-tagged protein were dialyzed into PBS supplemented with 2 mm DTT.
###end p 20
###begin p 21
###xml 0 23 0 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Solution Binding Assays</italic>
###xml 1155 1157 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1274 1275 1258 1259 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Solution Binding Assays-For Nab2 binding to CT-Mlp1 and CT-Mlp1 truncation mutants, Sepharose-bound GST, GST-CT-Mlp1, or GST-CT2 and -4-7 (6 mug) was incubated with 2 mug of purified His-Nab2 at 4 degreesC in 1 ml of PBS supplemented with protease inhibitor mixture, 0.1 mg/ml BSA competitor, and 0.5% Triton X-100 for 1 h 30 min at 4degreesC with mixing. Unbound fractions were collected and the beads were washed three times with 1 ml of PBS for 5 min each. Bound fractions were eluted with loading buffer and samples were analyzed by SDS-PAGE followed immunoblotting with an anti-His antibody (Santa Cruz Biotechnology, Santa Cruz, CA). The intensities of the His-Nab2 bands in the bound fractions were quantitated by integration of the pixel densities of the bands using ImageJ version 1.4 software (National Institute of Health, MD; ) and percentage bound relative to CT-Mlp1 was calculated by dividing the His-Nab2 band intensity in each bound fraction by the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1. For Mlp1-NBD binding to Nab2-N, His-Nab2-N-WT, or ovalbumin coupled to CNBr-Sepharose beads (30 mul), as described previously (49), was incubated with purified His-Mlp1-NBD (20 mug) in 1 ml of PBS supplemented with protease inhibitor mixture, 2 mm DTT, and 0.5 mg/ml BSA for 1 h 30 min at 4 degreesC with mixing. Unbound fractions were collected and the beads were washed three times with 1 ml of PBS for 5 min each. Bound fractions were eluted with loading buffer and samples were analyzed by SDS-PAGE followed by Coomassie staining. For co-purification of Mlp1-NBD with Nab2-N, 50-ml cultures of DE3 cells expressing GST-Nab2-N or His-Mlp1-NBD were combined, collected, and lysed in 10 ml of PBS supplemented with protease inhibitor mixture by sonication. Lysates were cleared and incubated with glutathione-Sepharose for 2 has described previously for batch purification of GST fusion proteins. The beads were washed three times with 5 ml of PBS for 2 min each. Unbound, bound, and wash samples were analyzed by SDS-PAGE followed by Coomassie staining.
###end p 21
###begin p 22
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Solid Phase Binding Assay</italic>
###xml 104 110 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 192 193 191 192 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 324 325 323 324 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 339 340 338 339 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 701 702 679 680 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1137 1138 1115 1116 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1699 1700 1660 1661 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1702 1703 1663 1664 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1705 1706 1666 1667 <sub xmlns:xlink="http://www.w3.org/1999/xlink">4</sub>
###xml 1771 1772 1732 1733 <sub xmlns:xlink="http://www.w3.org/1999/xlink">X</sub>
###xml 1897 1898 1858 1859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1898 1901 1859 1862 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 2351 2352 2312 2313 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 2350 2352 2311 2313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 2437 2438 2398 2399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2446 2447 2407 2408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2463 2464 2424 2425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 2464 2467 2425 2428 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 2589 2590 2550 2551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 2583 2590 2544 2551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 2627 2628 2588 2589 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 2626 2628 2587 2589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 2688 2695 2649 2656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1285 1296 <span type="species:ncbi:3704">horseradish</span>
###xml 1492 1503 <span type="species:ncbi:3704">horseradish</span>
Solid Phase Binding Assay-Solid phase binding assays were performed essentially as described by Bayliss et al. (54). Microtiter Immulux HB plates (Dynex) were coated with 100 mul/well of 125 nm GST, GST-Nab2-N (residues 1-97), GST-Nab2-N-F72D, GST-Nab2-N-F73D, or GST-Nab2-N-F73W in coating buffer (PBS supplemented with 2 mm DTT and 0.2 mm phenylmethylsulfonyl fluoride) for 16 h at 4 degreesC on a rocker. After adsorption, plates were washed three times by immersion in PBS and incubated in 100 mul of binding buffer (coating buffer supplemented with 3% BSA and 0.1% Tween 20) overnight at 4 degreesC on a rocker. Binding reactions were carried out for 2 h at 4 degreesC with 100 mul/well of 1-5 mum S-Tag-Mlp1-NBD (residues 1586-1768) protein in binding buffer. After binding, plates were washed three times by immersion in binding buffer without BSA and proteins were cross-linked for 15 min at room temperature by incubation in 1 mg/ml 1-ethyl-3-(3-dimethyl-aminopropyl)carboiimide (Pierce) in the same buffer. The wells were then washed for 20 min in PBS-T (PBS supplemented with 0.2% Tween 20), 10 min with PBS-T containing 100 mm ethanolamine, and finally incubated for 10 min in PBS-T containing 3% BSA. The bound S-tagged proteins were detected by incubation with S-protein-horseradish peroxidase conjugate (Novagen) in coating buffer containing 1% BSA and 0.1% Tween 20 for 1 h at 4degreesC on rocker. The plates were washed three times by immersion in PBS. Then, 100 mul/well of horseradish peroxidase substrate (1-Steptrade mark Turbo TMB (3,3'5,5'-tetramethylbenzidine)-ELISA (Pierce)) was added for 30 min at room temperature and the reaction was stopped by addition of 100 mul of 2 m H2SO4. The absorbance of the samples was measured at 450 nm with an ELX808 Ultra Microplate Reader with KCjunior software (Bio-Tek Instruments, Inc.). For each plate, average absorbance values at A450 were determined for GST and GST-Nab2-N proteins at each S-Tag-Mlp1-NBD concentration from triplicate samples. Background GST absorbance values were subtracted from those of the GST-Nab2 proteins. From three plates, absorbance values for GST-Nab2-N proteins at each S-Tag-Mlp1-NBD concentration were used to generate saturation binding curves by non-linear regression using Prism 4 software (GraphPad Software, Inc.) and calculate the mean apparent Kd. Standard error of the mean (S.E.; standard deviation divided by the square root of n, where n = 3) values of A450 readings from triplicate samples of GST-Nab2-N proteins at each S-Tag-Mlp1-NBD concentration for binding curves in Fig. 4B and S.E. values of triplicate mean Kd values for GST-Nab2-N protein binding to S-Tag-Mlp1-NBD in Table 2 were calculated using Prism 4 software.
###end p 22
###begin p 23
###xml 0 7 0 7 <label xmlns:xlink="http://www.w3.org/1999/xlink">TABLE 2</label>
###xml 7 71 7 71 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD</bold>
###xml 92 93 92 93 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 91 93 91 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 7 137 7 135 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="24"><bold>Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD</bold> Data represent the <italic>K<sub>d</sub></italic> means &#177; S.E. from triplicate experiments.</p>
###xml 7 137 7 135 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="24"><bold>Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD</bold> Data represent the <italic>K<sub>d</sub></italic> means &#177; S.E. from triplicate experiments.</p></caption>
###xml 137 143 135 141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N</bold>
###xml 137 143 135 141 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Nab2-N</bold></th>
###xml 143 147 141 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mlp1</bold>
###xml 143 147 141 145 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold>Mlp1</bold></th>
###xml 148 149 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 147 149 145 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 147 158 145 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>K<sub>d</sub></italic> apparent</bold>
###xml 147 158 145 156 <th xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> apparent</bold></th>
###xml 137 158 135 156 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th colspan="1" rowspan="1" align="center" valign="top"><bold>Nab2-N</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mlp1</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> apparent</bold></th></tr>
###xml 137 158 135 156 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Nab2-N</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mlp1</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> apparent</bold></th></tr></thead>
###xml 158 158 156 156 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"/>
###xml 158 158 156 156 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"/>
###xml 161 162 158 159 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 161 162 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink"><sc>m</sc></italic>
###xml 158 162 156 159 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td>
###xml 158 162 156 159 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr>
###xml 162 177 159 174 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-WT </td>
###xml 177 187 174 184 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td>
###xml 187 202 184 197 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 1.26 &#177; 0.38 </td>
###xml 162 202 159 197 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-WT </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.26 &#177; 0.38 </td></tr>
###xml 202 219 197 214 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F72D </td>
###xml 219 229 214 224 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td>
###xml 229 244 224 237 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 2.31 &#177; 1.06 </td>
###xml 202 244 197 237 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F72D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.31 &#177; 1.06 </td></tr>
###xml 244 261 237 254 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73D </td>
###xml 261 271 254 264 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td>
###xml 271 287 264 280 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td>
###xml 244 287 237 280 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr>
###xml 287 304 280 297 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73W </td>
###xml 304 314 297 307 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td>
###xml 314 329 307 320 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> 0.83 &#177; 0.18 </td>
###xml 287 329 280 320 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73W </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.83 &#177; 0.18 </td></tr>
###xml 329 334 320 325 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="left" valign="top"> GST </td>
###xml 334 344 325 335 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td>
###xml 344 360 335 351 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td>
###xml 329 360 320 351 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="1" rowspan="1" align="left" valign="top"> GST </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr>
###xml 158 360 156 351 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-WT </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.26 &#177; 0.38 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F72D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.31 &#177; 1.06 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73W </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.83 &#177; 0.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr></tbody>
###xml 137 360 135 351 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Nab2-N</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mlp1</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> apparent</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-WT </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.26 &#177; 0.38 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F72D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.31 &#177; 1.06 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73W </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.83 &#177; 0.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr></tbody></table>
###xml 0 360 0 351 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="tbl2"><label>TABLE 2</label><caption><p textid="24"><bold>Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD</bold> Data represent the <italic>K<sub>d</sub></italic> means &#177; S.E. from triplicate experiments.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="top"><bold>Nab2-N</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold>Mlp1</bold></th><th colspan="1" rowspan="1" align="center" valign="top"><bold><italic>K<sub>d</sub></italic> apparent</bold></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"> &#956;<italic><sc>m</sc></italic></td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-WT </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 1.26 &#177; 0.38 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F72D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 2.31 &#177; 1.06 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73D </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST-Nab2-N-F73W </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> 0.83 &#177; 0.18 </td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top"> GST </td><td colspan="1" rowspan="1" align="center" valign="top"> Mlp1-NBD </td><td colspan="1" rowspan="1" align="center" valign="top"> Not detectable </td></tr></tbody></table></table-wrap>
TABLE 2Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD Data represent the Kd means +/- S.E. from triplicate experiments.Nab2-NMlp1Kd apparent mum GST-Nab2-N-WT  Mlp1-NBD  1.26 +/- 0.38  GST-Nab2-N-F72D  Mlp1-NBD  2.31 +/- 1.06  GST-Nab2-N-F73D  Mlp1-NBD  Not detectable  GST-Nab2-N-F73W  Mlp1-NBD  0.83 +/- 0.18  GST  Mlp1-NBD  Not detectable
###end p 23
###begin p 24
###xml 0 64 0 64 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD</bold>
###xml 85 86 85 86 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 84 86 84 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
Dissociation constants for Nab2-N wild-type/mutants and Mlp1-NBD Data represent the Kd means +/- S.E. from triplicate experiments.
###end p 24
###begin p 25
###xml 5 38 1 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RGG-Nab2-GFP Relocalization Assay</italic>
###xml 300 302 292 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 540 547 524 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-MLP1</italic>
###xml 559 562 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1</italic>
###xml 574 577 558 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT2</italic>
###xml 589 592 573 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT3</italic>
###xml 604 607 588 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT4</italic>
###xml 619 622 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT5</italic>
###xml 634 642 618 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLP1-NBD</italic>
###xml 104 109 <span type="species:ncbi:4932">yeast</span>
DeltaRGG-Nab2-GFP Relocalization Assay-To examine the effect of Mlp1 expression on Nab2 localization in yeast cells, we exploited a previously developed assay where relocalization of a largely cytoplasmic Nab2 mutant fused to GFP, DeltaRGG-Nab2-GFP, to the nucleus is monitored upon Mlp1 expression (38). For analysis of the effect of expression of CT-Mlp1, CT-Mlp1 truncation mutants CT1-5 or Mlp1-NBD on the localization of DeltaRGG-Nab2-GFP, wild-type W303 cells expressing DeltaRGG-Nab2-GFP (pAC1036) and containing galactose-inducible CT-MLP1 (pAC1690), CT1 (pAC1696), CT2 (pAC1695), CT3 (pAC1694), CT4 (pAC1693), CT5 (pAC1692), MLP1-NBD (pAC2075), or vector control (pPS295) were grown in minimal media with 2% glucose overnight at 30 degreesC, transferred to minimal media with 2% galactose, and grown to log phase at 30 degreesC. For all samples, the localization of DeltaRGG-Nab2-GFP was examined by direct fluorescence microscopy.
###end p 25
###begin p 26
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Fluorescence in Situ Hybridization (FISH)</italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref32">32</xref>
###xml 175 182 175 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-MLP1</italic>
###xml 194 197 194 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1</italic>
###xml 209 212 209 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT2</italic>
###xml 224 227 224 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT3</italic>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT4</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT5</italic>
###xml 269 273 269 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MLP1</italic>
###xml 274 277 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NBD</italic>
###xml 473 477 461 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 492 496 476 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 502 509 482 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 527 531 507 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 542 546 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 552 553 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 565 574 541 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 589 598 565 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 801 807 771 777 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 809 811 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref55">55</xref>
Fluorescence in Situ Hybridization (FISH)-The intracellular localization of poly(A) RNA was assayed by FISH (32). Briefly, wild-type W303 cells containing galactose-inducible CT-MLP1 (pAC1690), CT1 (pAC1696), CT2 (pAC1695), CT3 (pAC1694), CT4 (pAC1693), CT5 (pAC1692), MLP1-NBD (pAC2075), or vector control (pPS295) were grown in minimal media with 2% glucose overnight at 30 degreesC, transferred to minimal media with 2% galactose, and grown to log phase at 30 degreesC. NAB2Delta cells or NAB2Delta mex67-5 cells containing NAB2 (pAC717), nab2 DeltaN (pAC1152), nab2 F72D (pAC2351), or nab2 F73D (pAC2352) were grown in minimal media with 2% glucose overnight, transferred to minimal media with 2% glucose, and grown to log phase at 30 degreesC. Cells were prepared as previously described by Wong et al. (55). A digoxigenin-labeled oligo(dT) probe and fluorescein isothiocyanate-conjugated anti-digoxigenin antibody (1:200 dilution, Roche Molecular Biochemicals) were used to localize poly(A) RNA. For all samples, cells were examined by fluorescence microscopy. Cells were also stained with 4',6-diamidino-2-phenylindole-dihydrochloride (DAPI) to detect chromatin and hence the position of the nucleus.
###end p 26
###begin p 27
###xml 106 165 106 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D, nab2 F73D, mex67-5 NAB2, mex67-5 nab2 F72D</italic>
###xml 171 188 171 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 970 974 970 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 979 983 979 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1013 1025 1013 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1030 1042 1030 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2</italic>
###xml 1127 1131 1127 1131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1165 1169 1165 1169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1173 1185 1173 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1265 1269 1265 1269 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1323 1327 1323 1327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
To quantitate the percentage of cells processed for FISH that showed nuclear accumulation of poly(A) RNA, NAB2, nab2 F72D, nab2 F73D, mex67-5 NAB2, mex67-5 nab2 F72D, and mex67-5 nab2 F73D cells probed with oligo(dT) to visualize poly(A) RNA and 10 fields of cells for each strain were imaged. For each field of cells, cells were counted and scored using ImageJ version 1.4 software, and the percentage of cells with nuclear poly(A) RNA was calculated. Cells were scored as showing nuclear poly(A) RNA if the fluorescent signal in the nucleus was greater than the signal in the cytoplasm. The mean percentage of cells with nuclear poly(A) RNA was calculated from the percentages in the 10 fields of cells. Variation in the percentage nuclear poly(A) RNA in each field from the mean was assessed by standard deviation (square root of the mean squared). All scoring of nuclear poly(A) RNA was performed blind to avoid biasing results. In each field of cells, at least 195 NAB2 and nab2 mutant cells and at least 43 mex67-5 NAB2 and mex67-5 nab2 mutant cells were counted. The fold increase in nuclear poly(A) RNA accumulation in nab2 mutant cells relative to that in NAB2 or mex67-5 NAB2 cells was calculated by dividing the mean percentage of nuclear poly(A) RNA in nab2 mutant cells by the mean percentage in corresponding NAB2 wild-type cells.
###end p 27
###begin p 28
###xml 0 10 0 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Microscopy</italic>
Microscopy-Cells expressing DeltaRGG-Nab2-GFP or processed for FISH were visualized by using filters from Chroma Technology (Brattleboro, VT) and an Olympus BX60 direct fluorescence microscope equipped with a photometric Quantix digital camera from Roper Scientific (Tucson, AZ). All images were captured using IP Lab Spectrum software.
###end p 28
###begin p 29
###xml 0 21 0 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2 Functional Assay</italic>
###xml 22 29 22 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vivo</italic>
###xml 206 210 206 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 232 236 232 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 241 248 241 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 252 264 252 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8, NAB2</italic>
###xml 286 290 282 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 296 303 288 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 311 315 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 321 326 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEX67</italic>
###xml 359 371 343 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 TRP1</italic>
###xml 388 395 372 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 401 405 385 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 411 417 391 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 425 429 405 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 435 439 411 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YRA1</italic>
###xml 472 483 444 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 TRP1</italic>
###xml 514 523 486 495 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 575 579 547 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 590 594 562 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 600 601 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 613 622 581 590 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 637 646 605 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 657 661 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">LEU2</italic>
###xml 690 691 658 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 694 695 662 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 789 790 751 752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 793 794 755 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 865 866 827 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 866 869 828 831 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 917 918 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1039 1040 988 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1043 1044 992 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1070 1079 1019 1028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 1121 1122 1070 1071 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1220 1229 1169 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 1251 1253 1200 1202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref56">56</xref>
###xml 1266 1270 1215 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1277 1281 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1287 1294 1228 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 1299 1303 1240 1244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1309 1315 1246 1252 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 1332 1342 1269 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 1348 1360 1281 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 1365 1374 1298 1307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1395 1399 1328 1332 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1456 1460 1383 1387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1469 1473 1392 1396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1479 1486 1398 1405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 1503 1518 1422 1437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 1523 1532 1442 1451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1553 1557 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1614 1615 1527 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1618 1619 1531 1532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1690 1691 1603 1604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1691 1694 1604 1607 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 1730 1731 1642 1643 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1734 1735 1646 1647 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-</sup>
###xml 1941 1942 1847 1848 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1942 1945 1848 1851 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 1989 1990 1895 1896 <sub xmlns:xlink="http://www.w3.org/1999/xlink">X</sub>
Nab2 Functional Assay-In vivo functional analysis of Nab2 was carried out through a standard plasmid shuffle assay combined with serial dilution and spotting or growth curves. To generate single mutants of nab2 or double mutants of nab2 and mex67-5 or yra1-8, NAB2Delta cells (ACY427), NAB2Delta mex67-5 cells (NAB2Delta MEX67Delta cells (SWY3601) containing mex67-5 TRP1 plasmid (pRS314-mex67-5)) or NAB2Delta yra1-8 cells (NAB2Delta YRA1Delta cells (FSY2327) containing yra1-8 TRP1 plasmid (pFS2152)) containing NAB2 URA3 maintenance plasmid (pAC636) were transformed with NAB2 (pAC717), nab2 DeltaN (pAC1152), nab2 F72D (pAC2351), or nab2 F73D (pAC2352) LEU2 plasmids and selected on Leu-Ura- minimal media with 2% glucose. Cells were grown overnight at 30 degreesC to saturation in Leu-Ura- minimal media with 2% glucose. Cell concentrations were normalized by A600 and cultures were serially diluted in sterile H2O to obtain approximately10,000, 1000, 100, 10, or 1 cell per 3-mul volume. These dilutions were spotted onto control Leu-Ura- minimal media, where the NAB2 URA3 maintenance plasmid is maintained, or Ura- minimal media containing 5-fluoroorotic acid (5-FOA), which selects for cells that have lost the NAB2 URA3 maintenance plasmid (56). Growth of NAB2Delta, NAB2Delta mex67-5, or NAB2Delta yra1-8 cells harboring NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D as the sole copy of nab2 was examined at 30 degreesC. For growth curve analysis, NAB2Delta or NAB2Delta mex67-5 cells harboring NAB2, nab2 F72D, or nab2 F73D as the sole copy of nab2 were grown overnight at 30 degreesC to saturation in Leu-Ura- minimal media with 2% glucose. Cell concentrations were normalized by A600, diluted 100-fold in 100 mul of Leu-Ura- minimal media with 2% glucose and added to wells of a MicroWell F96 microtiter plate (Nunc). Samples were loaded in duplicate. Cells in plate wells were grown at 30 degreesC with shaking and absorbance at A600 was measured every 30 min for 40 h in an ELX808 Ultra Microplate Reader with KCjunior software (Bio-Tek Instruments, Inc.). Duplicate sample absorbance for time points were averaged and plotted using Microsoft Excel for Mac 2004 (Microsoft Corp.).
###end p 29
###begin title 30
RESULTS
###end title 30
###begin p 31
###xml 0 55 0 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Identification of a Minimal Nab2-binding Region in Mlp1</italic>
###xml 202 210 202 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 306 308 306 308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 722 723 722 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 716 723 716 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 836 844 836 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 849 856 849 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 887 895 887 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1237 1238 1237 1238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1231 1238 1231 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
Identification of a Minimal Nab2-binding Region in Mlp1-Previous work demonstrated that the globular, acidic C-terminal domain of Mlp1 (CT-Mlp1, residues 1490-1875) interacts with the hnRNP, Nab2, both in vitro and in vivo and that ectopic expression of CT-Mlp1 causes nuclear accumulation of poly(A) RNA (38). These data indicate that Mlp1 is involved in poly(A) RNA export and suggest that one function of Nab2 is to serve as a molecular link between Mlp1 and poly(A) RNA. To test this model and gain further insight into the molecular basis for the Nab2/Mlp1 interaction, we employed a series of CT-Mlp1 truncation mutants with progressive deletions from the C-terminal end of Mlp1 (truncation mutants CT1-5, see Fig. 1A) to map the region within CT-Mlp1 that interacts directly with Nab2. These truncation mutants were used in both in vitro and in vivo binding assays with Nab2. For in vitro binding, recombinant GST, GST-CT-Mlp1, GST-CT2, CT4, or CT5 bound to glutathione beads was incubated with soluble recombinant His-Nab2 and the bound and unbound fractions were analyzed by immunoblotting with anti-His antibody to detect bound Nab2. The results were quantitated as described under "Experimental Procedures." As shown in Fig. 1B, we found that CT-Mlp1 CT2 (residues 1490-1779) binds to Nab2 with similar affinity (98% bound) as intact CT-Mlp1 (residues 1490-1875), whereas CT4 (residues 1490-1682) binds more weakly to Nab2 (16% bound) compared with CT-Mlp1, and CT5 (residues 1490-1585) shows no binding to Nab2 (1% bound). As a control, GST alone does not bind to Nab2. This result suggests that the Nab2-binding region within CT-Mlp1 lies within residues 1490-1779.
###end p 31
###begin p 32
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 381 388 381 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 643 644 643 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 637 644 637 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
The observation that CT-Mlp1 residues 1490-1779 (CT2) binds to Nab2, but residues 1490-1585 (CT5) does not interact defines the C-terminal end of the minimal Nab2-binding region within CT-Mlp1. To further delineate the N-terminal end of the minimal Nab2-binding region, we generated two additional CT-Mlp1 truncation mutants, CT6 (residues 1586-1779) and CT7 (residues 1677-1779) (Fig. 1A). Recombinant GST, GST-CT-Mlp1, GST-CT6, or GST-CT7 bound to glutathione beads was incubated with soluble recombinant His-Nab2 and bound and unbound fractions were analyzed by immunoblotting with anti-His antibody to detect bound Nab2. As shown in Fig. 1C, we found that CT-Mlp1 mutant CT6 (residues 1586-1779) binds to Nab2 to the same extent (>100% bound) as the intact CT-Mlp1 (residues 1490-1875), whereas CT7 (residues 1677-1779) does not bind to Nab2 (2% bound). These data indicate that the Nab2-binding region within CT-Mlp1 resides within residues 1586-1779.
###end p 32
###begin p 33
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 89 9 89 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.</bold>
###xml 89 90 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;7</italic>
###xml 193 201 193 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlp1-NBD</italic>
###xml 216 217 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 284 292 284 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 383 390 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-Mlp1</italic>
###xml 431 444 431 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT2, CT4, CT5</italic>
###xml 532 536 532 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2</italic>
###xml 551 552 551 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 565 566 565 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 789 794 789 794 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 811 812 811 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 879 887 879 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 919 926 919 926 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-Mlp1</italic>
###xml 967 975 967 975 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT6, CT7</italic>
###xml 1062 1066 1062 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2</italic>
###xml 1081 1082 1081 1082 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 1095 1096 1095 1096 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1319 1324 1319 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 1341 1342 1341 1342 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1508 1513 1504 1509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;5</italic>
###xml 1653 1655 1645 1647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1744 1747 1732 1735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vec</italic>
###xml 1822 1825 1810 1813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 9 1844 9 1832 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34"><bold>Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.</bold><italic>A</italic>, schematic depicting sizes of CT-Mlp1 truncation mutants (<italic>CT1&#8211;7</italic>) and the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) constructed. <italic>B</italic>, CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) binds to Nab2 <italic>in vitro</italic>, but mutant CT5 (residues 1490&#8211;1585) does not bind to Nab2. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT2, CT4, CT5</italic>) bound to glutathione-Sepharose beads were incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>C</italic>, CT-Mlp1 truncation mutant CT6 (residues 1586&#8211;1779) binds to Nab2 <italic>in vitro</italic>. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT6, CT7</italic>) bound to glutathione-Sepharose beads was incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>D</italic>, expression of CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) causes relocalization of &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells expressing a Nab2 mutant fused to GFP (&#916;RGG-Nab2-GFP), which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as a control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p>
###xml 9 1844 9 1832 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34"><bold>Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.</bold><italic>A</italic>, schematic depicting sizes of CT-Mlp1 truncation mutants (<italic>CT1&#8211;7</italic>) and the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) constructed. <italic>B</italic>, CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) binds to Nab2 <italic>in vitro</italic>, but mutant CT5 (residues 1490&#8211;1585) does not bind to Nab2. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT2, CT4, CT5</italic>) bound to glutathione-Sepharose beads were incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>C</italic>, CT-Mlp1 truncation mutant CT6 (residues 1586&#8211;1779) binds to Nab2 <italic>in vitro</italic>. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT6, CT7</italic>) bound to glutathione-Sepharose beads was incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>D</italic>, expression of CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) causes relocalization of &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells expressing a Nab2 mutant fused to GFP (&#916;RGG-Nab2-GFP), which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as a control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p></caption>
###xml 1844 1844 1832 1832 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200001"/>
###xml 0 1844 0 1832 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="34"><bold>Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.</bold><italic>A</italic>, schematic depicting sizes of CT-Mlp1 truncation mutants (<italic>CT1&#8211;7</italic>) and the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) constructed. <italic>B</italic>, CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) binds to Nab2 <italic>in vitro</italic>, but mutant CT5 (residues 1490&#8211;1585) does not bind to Nab2. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT2, CT4, CT5</italic>) bound to glutathione-Sepharose beads were incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>C</italic>, CT-Mlp1 truncation mutant CT6 (residues 1586&#8211;1779) binds to Nab2 <italic>in vitro</italic>. Recombinant GST, GST-CT-Mlp1 (<italic>CT-Mlp1</italic>), or the GST-CT-Mlp1 truncation mutant (<italic>CT6, CT7</italic>) bound to glutathione-Sepharose beads was incubated with recombinant His-tagged Nab2 (<italic>Nab2</italic>) and unbound (<italic>U</italic>) and bound (<italic>B</italic>) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated <italic>below</italic> the immunoblot. <italic>D</italic>, expression of CT-Mlp1 truncation mutant CT2 (residues 1490&#8211;1779) causes relocalization of &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells expressing a Nab2 mutant fused to GFP (&#916;RGG-Nab2-GFP), which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as a control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p></caption><graphic xlink:href="zbc0430852200001"/></fig>
###xml 1533 1538 <span type="species:ncbi:4932">yeast</span>
FIGURE 1.Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.A, schematic depicting sizes of CT-Mlp1 truncation mutants (CT1-7) and the Nab2-binding domain of Mlp1 (Mlp1-NBD) constructed. B, CT-Mlp1 truncation mutant CT2 (residues 1490-1779) binds to Nab2 in vitro, but mutant CT5 (residues 1490-1585) does not bind to Nab2. Recombinant GST, GST-CT-Mlp1 (CT-Mlp1), or the GST-CT-Mlp1 truncation mutant (CT2, CT4, CT5) bound to glutathione-Sepharose beads were incubated with recombinant His-tagged Nab2 (Nab2) and unbound (U) and bound (B) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated below the immunoblot. C, CT-Mlp1 truncation mutant CT6 (residues 1586-1779) binds to Nab2 in vitro. Recombinant GST, GST-CT-Mlp1 (CT-Mlp1), or the GST-CT-Mlp1 truncation mutant (CT6, CT7) bound to glutathione-Sepharose beads was incubated with recombinant His-tagged Nab2 (Nab2) and unbound (U) and bound (B) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated below the immunoblot. D, expression of CT-Mlp1 truncation mutant CT2 (residues 1490-1779) causes relocalization of DeltaRGG-Nab2-GFP to the nucleus. CT-Mlp1 and CT-Mlp1 truncation mutants (CT1-5) were expressed in yeast cells expressing a Nab2 mutant fused to GFP (DeltaRGG-Nab2-GFP), which displays localization throughout the cell (36), and DeltaRGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (Vec) was used as a control. Corresponding differential interference contrast (DIC) images are shown.
###end p 33
###begin p 34
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.</bold>
###xml 80 81 80 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 140 145 140 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;7</italic>
###xml 184 192 184 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlp1-NBD</italic>
###xml 207 208 207 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 275 283 275 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 374 381 374 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-Mlp1</italic>
###xml 422 435 422 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT2, CT4, CT5</italic>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2</italic>
###xml 542 543 542 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 556 557 556 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 780 785 780 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 870 878 870 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 910 917 910 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT-Mlp1</italic>
###xml 958 966 958 966 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT6, CT7</italic>
###xml 1053 1057 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2</italic>
###xml 1072 1073 1072 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 1086 1087 1086 1087 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1310 1315 1310 1315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">below</italic>
###xml 1332 1333 1332 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1499 1504 1495 1500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;5</italic>
###xml 1644 1646 1636 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1735 1738 1723 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vec</italic>
###xml 1813 1816 1801 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1524 1529 <span type="species:ncbi:4932">yeast</span>
Mapping of CT-Mlp1 reveals a Nab2-binding region between residues 1586 and 1779.A, schematic depicting sizes of CT-Mlp1 truncation mutants (CT1-7) and the Nab2-binding domain of Mlp1 (Mlp1-NBD) constructed. B, CT-Mlp1 truncation mutant CT2 (residues 1490-1779) binds to Nab2 in vitro, but mutant CT5 (residues 1490-1585) does not bind to Nab2. Recombinant GST, GST-CT-Mlp1 (CT-Mlp1), or the GST-CT-Mlp1 truncation mutant (CT2, CT4, CT5) bound to glutathione-Sepharose beads were incubated with recombinant His-tagged Nab2 (Nab2) and unbound (U) and bound (B) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated below the immunoblot. C, CT-Mlp1 truncation mutant CT6 (residues 1586-1779) binds to Nab2 in vitro. Recombinant GST, GST-CT-Mlp1 (CT-Mlp1), or the GST-CT-Mlp1 truncation mutant (CT6, CT7) bound to glutathione-Sepharose beads was incubated with recombinant His-tagged Nab2 (Nab2) and unbound (U) and bound (B) fractions were analyzed by immunoblotting with anti-His antibody. The percentage of His-Nab2 band intensity in each bound fraction relative to the His-Nab2 band intensity in the bound fraction of GST-CT-Mlp1 is indicated below the immunoblot. D, expression of CT-Mlp1 truncation mutant CT2 (residues 1490-1779) causes relocalization of DeltaRGG-Nab2-GFP to the nucleus. CT-Mlp1 and CT-Mlp1 truncation mutants (CT1-5) were expressed in yeast cells expressing a Nab2 mutant fused to GFP (DeltaRGG-Nab2-GFP), which displays localization throughout the cell (36), and DeltaRGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (Vec) was used as a control. Corresponding differential interference contrast (DIC) images are shown.
###end p 34
###begin p 35
###xml 20 27 20 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 62 70 62 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 255 262 251 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 264 266 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 350 352 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 467 469 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 544 546 536 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref37">37</xref>
###xml 548 550 540 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref57">57</xref>
###xml 608 610 600 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 744 746 728 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 859 866 839 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 894 902 874 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 927 934 907 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 1044 1051 1024 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink">GAL1&#8211;10</italic>
###xml 1275 1277 1255 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref58">58</xref>
###xml 1642 1643 1614 1615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1636 1643 1608 1615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>D</italic></xref>
###xml 2213 2220 2173 2180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 732 737 <span type="species:ncbi:4932">yeast</span>
###xml 1011 1016 <span type="species:ncbi:4932">yeast</span>
###xml 1223 1238 <span type="species:ncbi:10633">simian virus 40</span>
###xml 1240 1244 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
###xml 1290 1295 <span type="species:ncbi:4932">yeast</span>
We used a secondary in vivo Nab2 binding assay to confirm the in vitro data mapping the Nab2-binding region of Mlp1 to residues 1586-1779. Previously, we developed a DeltaRGG-Nab2 relocalization assay that reports on the interaction between Nab2 and Mlp1 in vivo (38). In contrast to wild-type Nab2, which shows nuclear localization at steady-state (35), DeltaRGG-Nab2 shows diffuse nuclear and cytoplasmic localization at steady-state due to lack of the RGG domain (36), which is required for interaction with the Nab2 import receptor Kap104 (37, 57). Expression of CT-Mlp1, which localizes to the nucleus (38), causes nuclear relocalization of DeltaRGG-Nab2 fused to GFP (DeltaRGG-Nab2-GFP), which normally locates throughout the yeast cell (36). CT-Mlp1-induced relocalization of DeltaRGG-Nab2-GFP to the nucleus is consistent with CT-Mlp1 binding to Nab2 in vivo. Therefore, to confirm the in vitro binding data using this in vivo binding assay, we expressed CT-Mlp1 and CT-Mlp1 truncation mutants CT1-5 in yeast from a galactose-inducible GAL1-10 promoter. To ensure nuclear targeting of each of the CT-Mlp1 deletions, the CT1-5 sequences were fused to an engineered bipartite nuclear localization signal based on the simian virus 40 (SV40) nuclear localization signal (58). Wild-type yeast cells expressing DeltaRGG-Nab2-GFP were induced to express CT-Mlp1 and CT1-5 by the addition of galactose and the localization of DeltaRGG-Nab2-GFP was assessed by direct fluorescence microscopy. The expression and localization of CT-Mlp1 and CT1-5 were confirmed by immunoblotting and GFP fusion localization (data not shown). As shown in Fig. 1D, CT-Mlp1 truncation mutant CT1 (residues 1490-1811) and CT2 (residues 1490-1779) relocalize DeltaRGG-Nab2-GFP to the nucleus to a similar degree as the intact CT-Mlp1 (residues 1490-1875). Truncation mutants CT3 (residues 1490-1717) and CT4 (residues 1490-1682) partially relocalize DeltaRGG-Nab2-GFP to the nucleus compared with CT-Mlp1 and truncation mutant CT5 (residues 1490-1585) does not relocalize DeltaRGG-Nab2-GFP to the nucleus. This result indicates that CT-Mlp1 residues 1490-1779 binds to Nab2, whereas CT-Mlp1 residues 1490-1585 do not interact with Nab2 in vivo. Taken together, the Nab2 binding assays strongly suggest the Nab2-binding region within CT-Mlp1 maps to residues 1586-1779.
###end p 35
###begin p 36
###xml 0 74 0 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Nab2-binding Region of Mlp1 Causes Nuclear Accumulation of Poly(A) RNA</italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 986 992 986 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 360 365 <span type="species:ncbi:4932">yeast</span>
###xml 413 418 <span type="species:ncbi:4932">yeast</span>
The Nab2-binding Region of Mlp1 Causes Nuclear Accumulation of Poly(A) RNA-Expression of CT-Mlp1 (residues 1490-1875) causes nuclear accumulation of poly(A) RNA (38). To map the region within CT-Mlp1 that causes poly(A) RNA accumulation and assess whether it corresponds to the Nab2-binding region, we expressed CT-Mlp1 and CT-Mlp1 truncation mutants CT1-5 in yeast from a galactose-inducible promoter. Wild-type yeast cells were induced to express CT-Mlp1 and CT1-5 by the addition of galactose and samples were processed for FISH using an oligo(dT) probe to visualize bulk poly(A) RNA. CT-Mlp1 truncation mutants CT1 (residues 1490-1811) and CT2 (residues 1490-1779) cause nuclear accumulation of poly(A) RNA to a similar extent as the intact CT-Mlp1 (residues 1490-1875), CT3 (residues 1490-1717) causes partial nuclear accumulation of poly(A) RNA compared with CT-Mlp1, and CT4 (residues 1490-1682) and CT5 (residues 1490-1585) do not cause poly(A) RNA accumulation in the nucleus (Fig. 2). This result indicates that the region within CT-Mlp1 that is sufficient to cause nuclear accumulation of poly(A) RNA maps to residues 1490-1779. Thus, both the Nab2-binding and poly(A) RNA interacting regions of CT-Mlp1 reside within residues 1490-1779.
###end p 36
###begin p 37
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Delineation of the Mlp1-Nab2 Binding Domain (Mlp1-NBD)</italic>
###xml 195 203 195 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 598 599 598 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 592 599 592 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
Delineation of the Mlp1-Nab2 Binding Domain (Mlp1-NBD)-As a complement to our mapping using engineered deletions, we also isolated a proteolytic fragment of the intact CT-Mlp1 that bound to Nab2 in vitro and identified the Mlp1 tryptic peptides within this fragment by mass spectroscopy (see supplemental Fig. S1 and supplemental Table 1). We mapped these peptides within CT-Mlp1 and used the information to refine the C-terminal end of the Nab2-binding region of Mlp1 to residue 1768. We termed the final Nab2-binding region of Mlp1: Mlp1-Nab2-binding domain (Mlp1-NBD; residues 1586-1768) (Fig. 1A).
###end p 37
###begin p 38
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 129 9 129 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation.</bold>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;5</italic>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 229 230 229 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 264 271 264 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 477 480 477 480 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 9 499 9 499 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation.</bold> CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p>
###xml 9 499 9 499 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation.</bold> CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p></caption>
###xml 499 499 499 499 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200002"/>
###xml 0 499 0 499 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="39"><bold>Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation.</bold> CT-Mlp1 and CT-Mlp1 truncation mutants (<italic>CT1&#8211;5</italic>) were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown.</p></caption><graphic xlink:href="zbc0430852200002"/></fig>
###xml 195 200 <span type="species:ncbi:4932">yeast</span>
FIGURE 2.Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation. CT-Mlp1 and CT-Mlp1 truncation mutants (CT1-5) were expressed in yeast cells and poly(A) RNA (Poly(A)) was visualized by fluorescence in situ hybridization with an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown.
###end p 38
###begin p 39
###xml 0 120 0 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation.</bold>
###xml 161 166 161 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CT1&#8211;5</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 255 262 255 262 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 186 191 <span type="species:ncbi:4932">yeast</span>
Mapping of CT-Mlp1 defines a region between residues 1490 and 1779 sufficient to cause nuclear poly(A) RNA accumulation. CT-Mlp1 and CT-Mlp1 truncation mutants (CT1-5) were expressed in yeast cells and poly(A) RNA (Poly(A)) was visualized by fluorescence in situ hybridization with an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown.
###end p 39
###begin p 40
###xml 0 54 0 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink">The Mlp1-NBD Interacts with the Nab2 N-terminal Domain</italic>
###xml 214 222 214 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 224 226 224 226 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 379 387 379 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 681 682 681 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 675 682 675 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 948 955 948 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 984 991 984 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1292 1293 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1286 1293 1286 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 1680 1688 1680 1688 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1690 1692 1690 1692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1694 1696 1694 1696 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 948 955 <span type="species:ncbi:562">E. coli</span>
###xml 984 991 <span type="species:ncbi:562">E. coli</span>
###xml 1547 1552 <span type="species:ncbi:4932">yeast</span>
The Mlp1-NBD Interacts with the Nab2 N-terminal Domain-Recent domain analysis of the hnRNP Nab2 has established that the N-terminal domain of Nab2 (Nab2-N, residues 1-97) binds to both CT-Mlp1 and full-length Mlp1 in vitro (49). To determine whether the Nab2-binding domain of Mlp1 (Mlp1-NBD, residues 1586-1768) interacts directly with Nab2-N, we analyzed the interaction by an in vitro binding assay using purified recombinant proteins. A control protein, ovalbumin, or recombinant His-Nab2-N-WT (residues 1-97) coupled to Sepharose beads was incubated with soluble recombinant His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. As shown in Fig. 3A, Mlp1-NBD binds to Nab2-N-WT, but does not bind to control ovalbumin beads. To further support this direct interaction and test its specificity, we tested whether Mlp1-NBD can be co-purified with Nab2-N from a complex protein mixture. We combined cell lysates from E. coli expressing His-Mlp1-NBD and E. coli expressing GST-Nab2-N, incubated the mixed lysates with glutathione beads and analyzed the bound fraction by SDS-PAGE and Coomassie staining. We find that Mlp1-NBD does indeed co-purify with Nab2-N from a complex mixture of bacterial proteins, highlighting the specificity of this interaction (Fig. 3B). Together, the experiments demonstrate that the Nab2-binding domain of Mlp1 (residues 1586-1768) interacts directly with the N-terminal domain of Nab2 (residues 1-97). Importantly, previous studies show that the interaction between CT-Mlp1 and Nab2 in yeast lysate is insensitive to RNase treatment and therefore RNA-independent and also that Nab2-N does not interact with poly(A) RNA in vitro (38, 49). The direct interaction between Nab2-N and Mlp1-NBD is thus most likely RNA-independent as well.
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 117 9 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.</bold>
###xml 117 118 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 246 254 246 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 305 309 305 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oval</italic>
###xml 441 442 441 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 562 569 562 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 598 605 598 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 748 749 748 749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 783 793 783 793 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W1, W2, W3</italic>
###xml 807 808 807 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 869 870 869 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 919 927 919 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlp1-NBD</italic>
###xml 1105 1107 1097 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1196 1199 1184 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vec</italic>
###xml 1272 1275 1260 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1295 1296 1283 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1467 1471 1455 1459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 1472 1473 1460 1461 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1507 1514 1495 1502 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 9 1736 9 1724 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.</bold><italic>A</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) binds to the N-terminal domain of Nab2 (Nab2-N; residues 1&#8211;97) <italic>in vitro</italic>. His-Nab2-N (Nab2-N) or, as a control, ovalbumin (<italic>Oval</italic>.) coupled to Sepharose beads was incubated with His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. <italic>B</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD) co-purifies with the N-terminal domain of Nab2 (Nab2-N). Cell lysates from <italic>E. coli</italic> expressing His-Mlp1-NBD and <italic>E. coli</italic> expressing GST-Nab2-N were combined, incubated with glutathione beads, and beads were washed three times. Input combined lysate (<italic>I</italic>), unbound (<italic>U</italic>) fraction, three wash fractions (<italic>W1, W2, W3</italic>), and bound (<italic>B</italic>) fraction were analyzed by SDS-PAGE and Coomassie staining. <italic>C</italic>, expression of the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) relocalizes &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells expressing &#916;RGG-Nab2-GFP, which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. <italic>D</italic>, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) causes nuclear accumulation of poly(A) RNA. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast images are shown.</p>
###xml 9 1736 9 1724 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.</bold><italic>A</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) binds to the N-terminal domain of Nab2 (Nab2-N; residues 1&#8211;97) <italic>in vitro</italic>. His-Nab2-N (Nab2-N) or, as a control, ovalbumin (<italic>Oval</italic>.) coupled to Sepharose beads was incubated with His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. <italic>B</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD) co-purifies with the N-terminal domain of Nab2 (Nab2-N). Cell lysates from <italic>E. coli</italic> expressing His-Mlp1-NBD and <italic>E. coli</italic> expressing GST-Nab2-N were combined, incubated with glutathione beads, and beads were washed three times. Input combined lysate (<italic>I</italic>), unbound (<italic>U</italic>) fraction, three wash fractions (<italic>W1, W2, W3</italic>), and bound (<italic>B</italic>) fraction were analyzed by SDS-PAGE and Coomassie staining. <italic>C</italic>, expression of the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) relocalizes &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells expressing &#916;RGG-Nab2-GFP, which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. <italic>D</italic>, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) causes nuclear accumulation of poly(A) RNA. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast images are shown.</p></caption>
###xml 1736 1736 1724 1724 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200003"/>
###xml 0 1736 0 1724 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="42"><bold>The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.</bold><italic>A</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) binds to the N-terminal domain of Nab2 (Nab2-N; residues 1&#8211;97) <italic>in vitro</italic>. His-Nab2-N (Nab2-N) or, as a control, ovalbumin (<italic>Oval</italic>.) coupled to Sepharose beads was incubated with His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. <italic>B</italic>, the Nab2-binding domain of Mlp1 (Mlp1-NBD) co-purifies with the N-terminal domain of Nab2 (Nab2-N). Cell lysates from <italic>E. coli</italic> expressing His-Mlp1-NBD and <italic>E. coli</italic> expressing GST-Nab2-N were combined, incubated with glutathione beads, and beads were washed three times. Input combined lysate (<italic>I</italic>), unbound (<italic>U</italic>) fraction, three wash fractions (<italic>W1, W2, W3</italic>), and bound (<italic>B</italic>) fraction were analyzed by SDS-PAGE and Coomassie staining. <italic>C</italic>, expression of the Nab2-binding domain of Mlp1 (<italic>Mlp1-NBD</italic>) relocalizes &#916;RGG-Nab2-GFP to the nucleus. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells expressing &#916;RGG-Nab2-GFP, which displays localization throughout the cell (<xref ref-type="bibr" rid="ref36">36</xref>), and &#916;RGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (<italic>Vec</italic>) was used as control. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. <italic>D</italic>, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) causes nuclear accumulation of poly(A) RNA. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by fluorescence <italic>in situ</italic> hybridization with an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast images are shown.</p></caption><graphic xlink:href="zbc0430852200003"/></fig>
###xml 562 569 <span type="species:ncbi:562">E. coli</span>
###xml 598 605 <span type="species:ncbi:562">E. coli</span>
###xml 1014 1019 <span type="species:ncbi:4932">yeast</span>
###xml 1438 1443 <span type="species:ncbi:4932">yeast</span>
FIGURE 3.The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.A, the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586-1768) binds to the N-terminal domain of Nab2 (Nab2-N; residues 1-97) in vitro. His-Nab2-N (Nab2-N) or, as a control, ovalbumin (Oval.) coupled to Sepharose beads was incubated with His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. B, the Nab2-binding domain of Mlp1 (Mlp1-NBD) co-purifies with the N-terminal domain of Nab2 (Nab2-N). Cell lysates from E. coli expressing His-Mlp1-NBD and E. coli expressing GST-Nab2-N were combined, incubated with glutathione beads, and beads were washed three times. Input combined lysate (I), unbound (U) fraction, three wash fractions (W1, W2, W3), and bound (B) fraction were analyzed by SDS-PAGE and Coomassie staining. C, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) relocalizes DeltaRGG-Nab2-GFP to the nucleus. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells expressing DeltaRGG-Nab2-GFP, which displays localization throughout the cell (36), and DeltaRGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (Vec) was used as control. Corresponding differential interference contrast (DIC) images are shown. D, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) causes nuclear accumulation of poly(A) RNA. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells and poly(A) RNA (Poly(A)) was visualized by fluorescence in situ hybridization with an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast images are shown.
###end p 41
###begin p 42
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.</bold>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 237 245 237 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oval</italic>
###xml 432 433 432 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 553 560 553 560 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 589 596 589 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">I</italic>
###xml 739 740 739 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">U</italic>
###xml 774 784 774 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">W1, W2, W3</italic>
###xml 798 799 798 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 860 861 860 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 910 918 910 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mlp1-NBD</italic>
###xml 1096 1098 1088 1090 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 1187 1190 1175 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Vec</italic>
###xml 1263 1266 1251 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1286 1287 1274 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1458 1462 1446 1450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 1463 1464 1451 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1498 1505 1486 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 553 560 <span type="species:ncbi:562">E. coli</span>
###xml 589 596 <span type="species:ncbi:562">E. coli</span>
###xml 1005 1010 <span type="species:ncbi:4932">yeast</span>
###xml 1429 1434 <span type="species:ncbi:4932">yeast</span>
The Nab2-binding domain of Mlp1 directly interacts with Nab2 and causes nuclear accumulation of poly(A) RNA.A, the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586-1768) binds to the N-terminal domain of Nab2 (Nab2-N; residues 1-97) in vitro. His-Nab2-N (Nab2-N) or, as a control, ovalbumin (Oval.) coupled to Sepharose beads was incubated with His-Mlp1-NBD and bound fractions were analyzed by SDS-PAGE and Coomassie staining. B, the Nab2-binding domain of Mlp1 (Mlp1-NBD) co-purifies with the N-terminal domain of Nab2 (Nab2-N). Cell lysates from E. coli expressing His-Mlp1-NBD and E. coli expressing GST-Nab2-N were combined, incubated with glutathione beads, and beads were washed three times. Input combined lysate (I), unbound (U) fraction, three wash fractions (W1, W2, W3), and bound (B) fraction were analyzed by SDS-PAGE and Coomassie staining. C, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) relocalizes DeltaRGG-Nab2-GFP to the nucleus. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells expressing DeltaRGG-Nab2-GFP, which displays localization throughout the cell (36), and DeltaRGG-Nab2-GFP was visualized by direct fluorescence microscopy. Empty vector (Vec) was used as control. Corresponding differential interference contrast (DIC) images are shown. D, expression of the Nab2-binding domain of Mlp1 (Mlp1-NBD) causes nuclear accumulation of poly(A) RNA. CT-Mlp1 and Mlp1-NBD were expressed in yeast cells and poly(A) RNA (Poly(A)) was visualized by fluorescence in situ hybridization with an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast images are shown.
###end p 42
###begin p 43
###xml 182 189 182 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 498 499 490 491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 492 499 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>C</italic></xref>
###xml 829 830 821 822 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 823 830 815 822 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>D</italic></xref>
###xml 1189 1196 1181 1188 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 611 616 <span type="species:ncbi:4932">yeast</span>
To further compare the Mlp1-NBD (residues 1586-1768) with the intact CT-Mlp1, we asked whether the Mlp1-NBD can both interact with Nab2 and cause nuclear accumulation of poly(A) RNA in vivo. In the DeltaRGG-Nab2-GFP relocalization assay, we expressed nuclear-targeted CT-Mlp1 and Mlp1-NBD from a galactose-inducible promoter and found that Mlp1-NBD (residues 1586-1768) relocalizes most DeltaRGG-Nab2-GFP to the nucleus, although not quite to the same extent as CT-Mlp1 (residues 1490-1875) (Fig. 3C). To test if the expression of Mlp1-NBD affects poly(A) RNA localization, we expressed Mlp1-NBD and CT-Mlp1 in yeast cells and localized the poly(A) RNA by FISH with an oligo d(T) probe. We find that the Mlp1-NBD does induce accumulation of poly(A) RNA within the nucleus, although not quite to the same degree as CT-Mlp1 (Fig. 3D). These results indicate that the Mlp1-NBD (residues 1586-1768) within CT-Mlp1 is primarily responsible for CT-Mlp1-induced nuclear poly(A) RNA accumulation, but that small contributions are also made by other residues outside this region of CT-Mlp1. Overall, these data confirm that the Mlp1-NBD, like the intact CT-Mlp1, has the capacity both to bind Nab2 in vivo and to impact poly(A) RNA localization.
###end p 43
###begin p 44
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 338 339 338 339 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 337 339 337 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 448 449 448 449 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 447 449 447 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 480 481 465 466 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 489 490 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 483 490 468 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 492 499 477 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
To measure quantitatively the interaction between the Mlp1-NBD and Nab2-N, we examined the binding of S-Tag-Mlp1-NBD to GST-Nab2-N wild-type (WT) at increasing concentrations of S-Tag-Mlp1-NBD in a solid-phase microtiter plate binding assay (54). This analysis generated a saturation binding curve and an apparent dissociation constant (Kd) value for Mlp1-NBD binding to Nab2-N-WT. We find that Mlp1-NBD binds to wild-type Nab2-N with an apparent Kd of approximately1.3 +/- 0.4 mum (Fig. 4B, Table 2), indicating that the relative binding affinity between Mlp1-NBD and Nab2-N is in the micromolar range. The rather weak affinity between Mlp1 and Nab2 likely reflects the need for the Nab2/Mlp1 interaction to be transient during mRNA export.
###end p 44
###begin p 45
###xml 0 73 0 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Specific Amino Acid Substitutions Disrupt the Nab2-N/Mlp1-NBD Interaction</italic>
###xml 236 238 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 306 308 302 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 316 317 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 310 317 306 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 404 406 400 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 563 571 559 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 652 654 648 650 <sup xmlns:xlink="http://www.w3.org/1999/xlink">72</sup>
###xml 661 663 657 659 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 1057 1058 1053 1054 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1056 1058 1052 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1087 1088 1068 1069 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1121 1122 1102 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1115 1122 1096 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1124 1131 1105 1112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1222 1223 1203 1204 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1221 1223 1202 1204 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1252 1253 1218 1219 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1293 1294 1259 1260 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1287 1294 1253 1260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
###xml 1296 1303 1262 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 1358 1360 1324 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 1488 1490 1454 1456 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 1733 1735 1699 1701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
Specific Amino Acid Substitutions Disrupt the Nab2-N/Mlp1-NBD Interaction-The crystal structure of the N-terminal domain of Nab2 (Nab2-N, residues 1-97) shows that this domain is based on a five alpha-helix bundle with a PWI-like fold (49). A Nab2 hydrophobic patch centered on a phenylalanine residue, Phe73 (Fig. 4A), was proposed to be an important constituent of the Nab2/Mlp1 interaction interface (49). Consistent with this hypothesis, we showed that recombinant Nab2-N-F73D does not bind to Mlp1, whereas Nab2-N-F72D is still competent to bind Mlp1, in an in vitro bead binding assay. To assess the impact of amino acid substitutions at Nab2 Phe72 or Phe73 on the relative binding affinity of Nab2 for Mlp1, we measured the binding of S-Tag-Mlp1-NBD to GST-Nab2-N mutants F72D, F73D, or F73W at increasing concentrations of S-Tag-Mlp1-NBD in the solid-phase binding assay. We find that the interaction between Nab2-N-F73D and Mlp1-NBD is undetectable in this assay, whereas Mlp1-NBD binds to Nab2-N-F72D with roughly 2-fold lower relative affinity (Kd approximately 2.3 +/- 1.1 mum) compared with wild-type (Fig. 4B, Table 2). Furthermore, we find that Mlp1-NBD binds to Nab2-N-F73W with 1.5-fold higher affinity (Kd approximately 0.8 +/- 0.2 mum) compared with wild-type Nab2-N (Fig. 4B, Table 2). The data reveal that substituting Nab2-N residue Phe73 with Asp significantly reduces the relative binding affinity between Nab2-N and the Mlp1-NBD, supporting the idea that Nab2 Phe73 is critical for interaction with Mlp1. The impaired binding of Nab2-N to Mlp1-NBD seen with the hydrophilic substitution, F73D, together with the enhanced binding seen with the hydrophobic substitution, F73W, is consistent with the proposal (49) that hydrophobic interactions contribute significantly to the Nab2/Mlp1 interface.
###end p 45
###begin p 46
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 167 9 167 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.</bold>
###xml 167 169 167 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 279 283 279 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 305 311 305 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 313 315 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 325 334 325 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray</italic>
###xml 438 439 438 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 725 734 725 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-WT</italic>
###xml 754 765 754 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F72D</italic>
###xml 785 796 785 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F73D</italic>
###xml 819 830 819 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F73W</italic>
###xml 922 923 922 923 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 923 926 923 926 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 990 991 990 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 991 994 991 994 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 1093 1103 1093 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 1108 1109 1108 1109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1109 1112 1109 1112 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 1355 1356 1355 1356 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1354 1356 1354 1356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1385 1386 1370 1371 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1403 1404 1388 1389 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1402 1404 1387 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1433 1434 1403 1404 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1454 1455 1424 1425 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1453 1455 1423 1425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1484 1485 1439 1440 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1492 1499 1447 1454 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
###xml 9 1685 9 1640 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47"><bold>The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.</bold><italic>A,</italic> surface representation of the N-terminal domain of Nab2 (Nab2-N) showing the putative Mlp1 interaction site (<italic>gray</italic>) identified by Grant <italic>et al.</italic> (<xref ref-type="bibr" rid="ref49">49</xref>). Phe<sup>73</sup> (<italic>dark gray</italic>) is central to this site and its hydrophobic aromatic side chain is completely exposed to the solvent. <italic>B</italic>, the binding affinity of the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) for Nab2-N wild-type and mutants F72D, F73D, and F73W (residues 1&#8211;97) was measured quantitatively in a solid-phase binding assay (<xref ref-type="bibr" rid="ref54">54</xref>). Binding of S-Tag-Mlp1-NBD (Mlp1-NBD) to GST-Nab2-N wild-type (<italic>Nab2-N-WT</italic>), GST-Nab2-N-F72D (<italic>Nab2-N-F72D</italic>), GST-Nab2-N-F73D (<italic>Nab2-N-F73D</italic>), or GST-Nab2-N-F73W (<italic>Nab2-N-F73W</italic>) at increasing concentrations of S-Tag-Mlp1-NBD was measured at optical density of 450 nm (<italic>A</italic><sub>450</sub>) as described under &#8220;Experimental Procedures.&#8221; Measurements at <italic>A</italic><sub>450</sub> (amount bound) were used to generate saturation binding curves by non-linear regression. Standard <italic>error bars</italic> for <italic>A</italic><sub>450</sub> readings from triplicate samples of GST-Nab2-N-WT and mutants at each S-Tag-Mlp1-NBD concentration are indicated. These binding curves were used to calculate apparent dissociation constants for binding between Mlp1-NBD and Nab2-N wild-type (<italic>K<sub>d</sub></italic> &#8764; 1.3 &#177; 0.4 &#956;<sc>m</sc>), Nab2-N-F72D (<italic>K<sub>d</sub></italic> &#8764; 2.3 &#177; 1.1 &#956;<sc>m</sc>), or Nab2-N-F73W (<italic>K<sub>d</sub></italic> &#8764; 0.8 &#177; 0.2 &#956;<sc>m</sc>) (see <xref ref-type="table" rid="tbl2">Table 2</xref>). The weak binding between Mlp1-NBD and Nab2-N-F73D was indistinguishable from nonspecific binding, indicating that the F73D substitution essentially disrupts the Nab2/Mlp1 interaction.</p>
###xml 9 1685 9 1640 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="47"><bold>The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.</bold><italic>A,</italic> surface representation of the N-terminal domain of Nab2 (Nab2-N) showing the putative Mlp1 interaction site (<italic>gray</italic>) identified by Grant <italic>et al.</italic> (<xref ref-type="bibr" rid="ref49">49</xref>). Phe<sup>73</sup> (<italic>dark gray</italic>) is central to this site and its hydrophobic aromatic side chain is completely exposed to the solvent. <italic>B</italic>, the binding affinity of the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) for Nab2-N wild-type and mutants F72D, F73D, and F73W (residues 1&#8211;97) was measured quantitatively in a solid-phase binding assay (<xref ref-type="bibr" rid="ref54">54</xref>). Binding of S-Tag-Mlp1-NBD (Mlp1-NBD) to GST-Nab2-N wild-type (<italic>Nab2-N-WT</italic>), GST-Nab2-N-F72D (<italic>Nab2-N-F72D</italic>), GST-Nab2-N-F73D (<italic>Nab2-N-F73D</italic>), or GST-Nab2-N-F73W (<italic>Nab2-N-F73W</italic>) at increasing concentrations of S-Tag-Mlp1-NBD was measured at optical density of 450 nm (<italic>A</italic><sub>450</sub>) as described under &#8220;Experimental Procedures.&#8221; Measurements at <italic>A</italic><sub>450</sub> (amount bound) were used to generate saturation binding curves by non-linear regression. Standard <italic>error bars</italic> for <italic>A</italic><sub>450</sub> readings from triplicate samples of GST-Nab2-N-WT and mutants at each S-Tag-Mlp1-NBD concentration are indicated. These binding curves were used to calculate apparent dissociation constants for binding between Mlp1-NBD and Nab2-N wild-type (<italic>K<sub>d</sub></italic> &#8764; 1.3 &#177; 0.4 &#956;<sc>m</sc>), Nab2-N-F72D (<italic>K<sub>d</sub></italic> &#8764; 2.3 &#177; 1.1 &#956;<sc>m</sc>), or Nab2-N-F73W (<italic>K<sub>d</sub></italic> &#8764; 0.8 &#177; 0.2 &#956;<sc>m</sc>) (see <xref ref-type="table" rid="tbl2">Table 2</xref>). The weak binding between Mlp1-NBD and Nab2-N-F73D was indistinguishable from nonspecific binding, indicating that the F73D substitution essentially disrupts the Nab2/Mlp1 interaction.</p></caption>
###xml 1685 1685 1640 1640 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200004"/>
###xml 0 1685 0 1640 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="47"><bold>The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.</bold><italic>A,</italic> surface representation of the N-terminal domain of Nab2 (Nab2-N) showing the putative Mlp1 interaction site (<italic>gray</italic>) identified by Grant <italic>et al.</italic> (<xref ref-type="bibr" rid="ref49">49</xref>). Phe<sup>73</sup> (<italic>dark gray</italic>) is central to this site and its hydrophobic aromatic side chain is completely exposed to the solvent. <italic>B</italic>, the binding affinity of the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586&#8211;1768) for Nab2-N wild-type and mutants F72D, F73D, and F73W (residues 1&#8211;97) was measured quantitatively in a solid-phase binding assay (<xref ref-type="bibr" rid="ref54">54</xref>). Binding of S-Tag-Mlp1-NBD (Mlp1-NBD) to GST-Nab2-N wild-type (<italic>Nab2-N-WT</italic>), GST-Nab2-N-F72D (<italic>Nab2-N-F72D</italic>), GST-Nab2-N-F73D (<italic>Nab2-N-F73D</italic>), or GST-Nab2-N-F73W (<italic>Nab2-N-F73W</italic>) at increasing concentrations of S-Tag-Mlp1-NBD was measured at optical density of 450 nm (<italic>A</italic><sub>450</sub>) as described under &#8220;Experimental Procedures.&#8221; Measurements at <italic>A</italic><sub>450</sub> (amount bound) were used to generate saturation binding curves by non-linear regression. Standard <italic>error bars</italic> for <italic>A</italic><sub>450</sub> readings from triplicate samples of GST-Nab2-N-WT and mutants at each S-Tag-Mlp1-NBD concentration are indicated. These binding curves were used to calculate apparent dissociation constants for binding between Mlp1-NBD and Nab2-N wild-type (<italic>K<sub>d</sub></italic> &#8764; 1.3 &#177; 0.4 &#956;<sc>m</sc>), Nab2-N-F72D (<italic>K<sub>d</sub></italic> &#8764; 2.3 &#177; 1.1 &#956;<sc>m</sc>), or Nab2-N-F73W (<italic>K<sub>d</sub></italic> &#8764; 0.8 &#177; 0.2 &#956;<sc>m</sc>) (see <xref ref-type="table" rid="tbl2">Table 2</xref>). The weak binding between Mlp1-NBD and Nab2-N-F73D was indistinguishable from nonspecific binding, indicating that the F73D substitution essentially disrupts the Nab2/Mlp1 interaction.</p></caption><graphic xlink:href="zbc0430852200004"/></fig>
FIGURE 4.The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.A, surface representation of the N-terminal domain of Nab2 (Nab2-N) showing the putative Mlp1 interaction site (gray) identified by Grant et al. (49). Phe73 (dark gray) is central to this site and its hydrophobic aromatic side chain is completely exposed to the solvent. B, the binding affinity of the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586-1768) for Nab2-N wild-type and mutants F72D, F73D, and F73W (residues 1-97) was measured quantitatively in a solid-phase binding assay (54). Binding of S-Tag-Mlp1-NBD (Mlp1-NBD) to GST-Nab2-N wild-type (Nab2-N-WT), GST-Nab2-N-F72D (Nab2-N-F72D), GST-Nab2-N-F73D (Nab2-N-F73D), or GST-Nab2-N-F73W (Nab2-N-F73W) at increasing concentrations of S-Tag-Mlp1-NBD was measured at optical density of 450 nm (A450) as described under "Experimental Procedures." Measurements at A450 (amount bound) were used to generate saturation binding curves by non-linear regression. Standard error bars for A450 readings from triplicate samples of GST-Nab2-N-WT and mutants at each S-Tag-Mlp1-NBD concentration are indicated. These binding curves were used to calculate apparent dissociation constants for binding between Mlp1-NBD and Nab2-N wild-type (Kd approximately 1.3 +/- 0.4 mum), Nab2-N-F72D (Kd approximately 2.3 +/- 1.1 mum), or Nab2-N-F73W (Kd approximately 0.8 +/- 0.2 mum) (see Table 2). The weak binding between Mlp1-NBD and Nab2-N-F73D was indistinguishable from nonspecific binding, indicating that the F73D substitution essentially disrupts the Nab2/Mlp1 interaction.
###end p 46
###begin p 47
###xml 0 158 0 158 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.</bold>
###xml 158 160 158 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A,</italic>
###xml 270 274 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">gray</italic>
###xml 296 302 296 302 <italic xmlns:xlink="http://www.w3.org/1999/xlink">et al.</italic>
###xml 304 306 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 312 314 312 314 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 316 325 316 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink">dark gray</italic>
###xml 429 430 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 649 651 649 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref54">54</xref>
###xml 716 725 716 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-WT</italic>
###xml 745 756 745 756 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F72D</italic>
###xml 776 787 776 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F73D</italic>
###xml 810 821 810 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nab2-N-F73W</italic>
###xml 913 914 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 914 917 914 917 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 981 982 981 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 982 985 982 985 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 1084 1094 1084 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">error bars</italic>
###xml 1099 1100 1099 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1100 1103 1100 1103 <sub xmlns:xlink="http://www.w3.org/1999/xlink">450</sub>
###xml 1346 1347 1346 1347 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1345 1347 1345 1347 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1376 1377 1361 1362 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1394 1395 1379 1380 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1393 1395 1378 1380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1424 1425 1394 1395 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1445 1446 1415 1416 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 1444 1446 1414 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 1475 1476 1430 1431 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1483 1490 1438 1445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="tbl2">Table 2</xref>
The Nab2-binding domain of Mlp1 binds to the N-terminal domain of Nab2 with micromolar affinity and Nab2 F73D substitution disrupts the Nab2/Mlp1 interaction.A, surface representation of the N-terminal domain of Nab2 (Nab2-N) showing the putative Mlp1 interaction site (gray) identified by Grant et al. (49). Phe73 (dark gray) is central to this site and its hydrophobic aromatic side chain is completely exposed to the solvent. B, the binding affinity of the Nab2-binding domain of Mlp1 (Mlp1-NBD; residues 1586-1768) for Nab2-N wild-type and mutants F72D, F73D, and F73W (residues 1-97) was measured quantitatively in a solid-phase binding assay (54). Binding of S-Tag-Mlp1-NBD (Mlp1-NBD) to GST-Nab2-N wild-type (Nab2-N-WT), GST-Nab2-N-F72D (Nab2-N-F72D), GST-Nab2-N-F73D (Nab2-N-F73D), or GST-Nab2-N-F73W (Nab2-N-F73W) at increasing concentrations of S-Tag-Mlp1-NBD was measured at optical density of 450 nm (A450) as described under "Experimental Procedures." Measurements at A450 (amount bound) were used to generate saturation binding curves by non-linear regression. Standard error bars for A450 readings from triplicate samples of GST-Nab2-N-WT and mutants at each S-Tag-Mlp1-NBD concentration are indicated. These binding curves were used to calculate apparent dissociation constants for binding between Mlp1-NBD and Nab2-N wild-type (Kd approximately 1.3 +/- 0.4 mum), Nab2-N-F72D (Kd approximately 2.3 +/- 1.1 mum), or Nab2-N-F73W (Kd approximately 0.8 +/- 0.2 mum) (see Table 2). The weak binding between Mlp1-NBD and Nab2-N-F73D was indistinguishable from nonspecific binding, indicating that the F73D substitution essentially disrupts the Nab2/Mlp1 interaction.
###end p 47
###begin p 48
###xml 0 52 0 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Functional Significance of the Nab2/Mlp1 Interaction</italic>
###xml 224 231 224 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 312 316 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref35">35</xref>
###xml 710 712 706 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 746 750 742 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 784 793 776 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 822 832 814 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 838 845 826 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, F72D</italic>
###xml 849 858 837 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F73D LEU2</italic>
###xml 979 988 967 976 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 1064 1073 1052 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 1164 1173 1152 1161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1178 1187 1166 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1222 1226 1210 1214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1256 1257 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1250 1257 1238 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 1285 1289 1273 1277 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 1295 1296 1279 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1351 1360 1335 1344 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1365 1374 1349 1358 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1409 1413 1393 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1557 1558 1541 1542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1551 1558 1535 1542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1617 1619 1601 1603 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 1896 1898 1880 1882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref49">49</xref>
###xml 1900 1902 1884 1886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref51">51</xref>
###xml 445 450 <span type="species:ncbi:4932">yeast</span>
###xml 756 761 <span type="species:ncbi:4932">yeast</span>
Functional Significance of the Nab2/Mlp1 Interaction-With the knowledge gained from the Nab2-N structure and engineered Nab2 mutants, we proceeded to assess the functional consequence of disrupting the Nab2/Mlp1 interaction in vivo and define the way in which this interaction contributes to mRNA export. As the NAB2 gene is essential for viability (35), we examined whether Nab2-F73D or Nab2-F72D (as a control) could replace wild-type Nab2 in yeast cells. As a further control in these assays, we used a previously characterized Nab2 mutant, DeltaN, lacking the Nab2 N-terminal domain altogether (residues 4-97), which confers a severe slow growth phenotype when expressed as the only cellular copy of Nab2 (36). Using a plasmid shuffle assay, NAB2Delta yeast cells maintained by a NAB2 URA3 plasmid and also containing NAB2, nab2 DeltaN, F72D or F73D LEU2 test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control plates (where the NAB2 URA3 maintenance plasmid is retained) and plates containing 5-FOA to remove the NAB2 URA3 maintenance plasmid and leave the test plasmids as the sole cellular copies of Nab2. Both nab2 F72D and nab2 F73D cells grow similarly to wild-type NAB2 cells on 5-FOA plates (Fig. 5A). However, as anticipated, nab2 DeltaN cells show a slow growth phenotype. We confirmed that nab2 F72D and nab2 F73D cells grow similarly to wild-type NAB2 cells by measuring the optical density of the cells in liquid culture over time and generating quantitative growth curves for the cells (Fig. 5B). This result indicates that substituting Nab2 residue Phe73 with Asp and disrupting the Nab2/Mlp1 interaction does not significantly affect cell growth in a wild-type background. Additionally, given the knowledge that the N-terminal domain of Nab2 is required for proper Nab2 function (including binding to other proteins such as Gfd1 (49, 51)), the data suggest that the F73D substitution does not severely impact the overall structure of the Nab2 protein.
###end p 48
###begin p 49
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 18 9 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 9 114 9 114 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>nab2 F73D</italic> mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.</bold>
###xml 114 126 114 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, nab2 F73D</italic>
###xml 176 180 176 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 188 192 188 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 220 229 216 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 253 263 249 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 269 281 261 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 286 300 278 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D LEU2</italic>
###xml 454 455 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 482 491 468 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 545 549 531 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 557 561 543 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 587 602 569 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 607 616 589 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 703 704 685 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 704 707 686 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 763 775 745 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, nab2 F73D</italic>
###xml 827 831 809 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 857 867 835 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 873 885 847 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 890 899 864 873 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 970 974 938 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 975 976 943 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1194 1197 1162 1165 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1607 1611 1575 1579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1627 1636 1593 1602 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1656 1665 1620 1629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1687 1696 1649 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1779 1783 1741 1745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1799 1808 1761 1770 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1917 1926 1879 1888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 9 1982 9 1944 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="50"><bold><italic>nab2 F73D</italic> mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.</bold><italic>A, nab2 F73D</italic> cells are viable and grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>nab2 F73D</italic> cells confirms that they grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, nab2 F73D</italic> cells display nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 195 cells each (indicated to the right of DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>NAB2</italic>, 3.2 &#177; 1.0%; <italic>nab2 F72D</italic>, 3.9 &#177; 1.5%; and <italic>nab2 F73D</italic>, 8.2 &#177; 2.0%. Thus, <italic>nab2 F73D</italic> cells exhibit a 2.5-fold increase in nuclear poly(A) RNA accumulation relative to <italic>NAB2</italic> cells, whereas <italic>nab2 F72D</italic> cells show only a modest 1.2-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>nab2 F73D</italic> cells were typical of multiple independent experiments.</p>
###xml 9 1982 9 1944 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="50"><bold><italic>nab2 F73D</italic> mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.</bold><italic>A, nab2 F73D</italic> cells are viable and grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>nab2 F73D</italic> cells confirms that they grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, nab2 F73D</italic> cells display nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 195 cells each (indicated to the right of DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>NAB2</italic>, 3.2 &#177; 1.0%; <italic>nab2 F72D</italic>, 3.9 &#177; 1.5%; and <italic>nab2 F73D</italic>, 8.2 &#177; 2.0%. Thus, <italic>nab2 F73D</italic> cells exhibit a 2.5-fold increase in nuclear poly(A) RNA accumulation relative to <italic>NAB2</italic> cells, whereas <italic>nab2 F72D</italic> cells show only a modest 1.2-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>nab2 F73D</italic> cells were typical of multiple independent experiments.</p></caption>
###xml 1982 1982 1944 1944 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200005"/>
###xml 0 1982 0 1944 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="50"><bold><italic>nab2 F73D</italic> mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.</bold><italic>A, nab2 F73D</italic> cells are viable and grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>nab2 F73D</italic> cells confirms that they grow similarly to wild-type <italic>NAB2</italic> cells. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, nab2 F73D</italic> cells display nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 195 cells each (indicated to the right of DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>NAB2</italic>, 3.2 &#177; 1.0%; <italic>nab2 F72D</italic>, 3.9 &#177; 1.5%; and <italic>nab2 F73D</italic>, 8.2 &#177; 2.0%. Thus, <italic>nab2 F73D</italic> cells exhibit a 2.5-fold increase in nuclear poly(A) RNA accumulation relative to <italic>NAB2</italic> cells, whereas <italic>nab2 F72D</italic> cells show only a modest 1.2-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>nab2 F73D</italic> cells were typical of multiple independent experiments.</p></caption><graphic xlink:href="zbc0430852200005"/></fig>
FIGURE 5.nab2 F73D mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.A, nab2 F73D cells are viable and grow similarly to wild-type NAB2 cells. NAB2Delta cells maintained by a NAB2 URA3 plasmid and containing NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D LEU2 test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control and 5-FOA plates. Cells were grown at 30 degreesC. B, growth curve analysis of nab2 F73D cells confirms that they grow similarly to wild-type NAB2 cells. NAB2Delta cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown to saturation, diluted, and their optical density was measured at A600 for 40 h as described under "Experimental Procedures." C, nab2 F73D cells display nuclear accumulation of poly(A) RNA. NAB2Delta cells carrying only NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D plasmids were grown in liquid culture at 30 degreesC and poly(A) RNA (Poly(A)) was visualized by FISH using an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown. FISH results were quantitated as described under "Experimental Procedures" to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 195 cells each (indicated to the right of DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: NAB2, 3.2 +/- 1.0%; nab2 F72D, 3.9 +/- 1.5%; and nab2 F73D, 8.2 +/- 2.0%. Thus, nab2 F73D cells exhibit a 2.5-fold increase in nuclear poly(A) RNA accumulation relative to NAB2 cells, whereas nab2 F72D cells show only a modest 1.2-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in nab2 F73D cells were typical of multiple independent experiments.
###end p 49
###begin p 50
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>nab2 F73D</italic> mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.</bold>
###xml 105 117 105 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, nab2 F73D</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 179 183 179 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 211 220 207 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 244 254 240 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 260 272 252 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 277 291 269 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D LEU2</italic>
###xml 445 446 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 473 482 459 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 536 540 522 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 548 552 534 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 578 593 560 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 598 607 580 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 694 695 676 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 695 698 677 680 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 754 766 736 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, nab2 F73D</italic>
###xml 818 822 800 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 848 858 826 836 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 864 876 838 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 881 890 855 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 961 965 929 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 966 967 934 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1185 1188 1153 1156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1598 1602 1566 1570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1618 1627 1584 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1647 1656 1611 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1678 1687 1640 1649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1770 1774 1732 1736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1790 1799 1752 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 1908 1917 1870 1879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
nab2 F73D mutant cells grow similarly to wild-type cells but display nuclear accumulation of poly(A) RNA.A, nab2 F73D cells are viable and grow similarly to wild-type NAB2 cells. NAB2Delta cells maintained by a NAB2 URA3 plasmid and containing NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D LEU2 test plasmids were grown to saturation, serially diluted in 10-fold dilutions, and spotted on control and 5-FOA plates. Cells were grown at 30 degreesC. B, growth curve analysis of nab2 F73D cells confirms that they grow similarly to wild-type NAB2 cells. NAB2Delta cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown to saturation, diluted, and their optical density was measured at A600 for 40 h as described under "Experimental Procedures." C, nab2 F73D cells display nuclear accumulation of poly(A) RNA. NAB2Delta cells carrying only NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D plasmids were grown in liquid culture at 30 degreesC and poly(A) RNA (Poly(A)) was visualized by FISH using an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown. FISH results were quantitated as described under "Experimental Procedures" to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 195 cells each (indicated to the right of DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: NAB2, 3.2 +/- 1.0%; nab2 F72D, 3.9 +/- 1.5%; and nab2 F73D, 8.2 +/- 2.0%. Thus, nab2 F73D cells exhibit a 2.5-fold increase in nuclear poly(A) RNA accumulation relative to NAB2 cells, whereas nab2 F72D cells show only a modest 1.2-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in nab2 F73D cells were typical of multiple independent experiments.
###end p 50
###begin p 51
###xml 107 116 107 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 120 129 120 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 236 251 236 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 257 266 257 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 479 480 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 536 538 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 541 545 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 568 578 560 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 584 591 572 579 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, F72D</italic>
###xml 596 600 584 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F73D</italic>
###xml 685 694 673 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 804 813 792 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 907 908 895 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 901 908 889 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>C</italic></xref>
###xml 919 923 907 911 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2</italic>
###xml 929 930 913 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1003 1005 987 989 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
To determine whether disruption of the Nab2/Mlp1 interaction impacts mRNA export, we next assessed whether nab2 F72D or nab2 F73D cells show nuclear accumulation of poly(A) RNA in vivo. We examined poly(A) RNA localization in wild-type NAB2, nab2 F72D, and nab2 F73D cells by FISH and then quantitated the percentage of cells with nuclear poly(A) RNA accumulation as described under "Experimental Procedures." As a control, we also examined poly(A) RNA localization in nab2 DeltaN cells, which show nuclear accumulation of poly(A) RNA (36). NAB2Delta cells expressing NAB2, nab2 DeltaN, F72D, or F73D were processed for FISH using an oligo(dT) probe to visualize bulk poly(A) RNA. The nab2 F73D cells show a 2.5-fold increase in nuclear accumulation of poly(A) RNA compared with wild-type cells, whereas nab2 F72D cells show accumulation of poly(A) RNA in the nucleus comparable with wild-type cells (Fig. 5C). Control nab2 DeltaN cells show significant nuclear accumulation of poly(A) RNA as expected (36). This result suggests that the Nab2/Mlp1 interaction facilitates but is not absolutely required for mRNA export.
###end p 51
###begin p 52
###xml 490 499 490 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F72D</italic>
###xml 503 512 503 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 538 545 538 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 553 559 553 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 561 563 561 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 677 684 673 680 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 711 720 707 716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 756 766 752 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 772 779 764 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, F72D</italic>
###xml 783 792 775 784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F73D LEU2</italic>
###xml 896 913 888 905 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 977 989 969 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1005 1022 997 1014 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F72D</italic>
###xml 1052 1064 1044 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1078 1079 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1072 1079 1064 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1143 1155 1135 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2</italic>
###xml 1161 1162 1149 1150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 1227 1244 1215 1232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1263 1275 1251 1263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1396 1397 1384 1385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1390 1397 1378 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>B</italic></xref>
###xml 1421 1425 1409 1413 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 1431 1437 1415 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 1464 1473 1448 1457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 1509 1519 1493 1503 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 1525 1532 1505 1512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, F72D</italic>
###xml 1536 1545 1516 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F73D LEU2</italic>
###xml 1630 1646 1610 1626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 nab2 F73D</italic>
###xml 1710 1721 1690 1701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 NAB2</italic>
###xml 1735 1736 1715 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1729 1736 1709 1716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>A</italic></xref>
###xml 1747 1763 1727 1743 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 nab2 F72D</italic>
###xml 1793 1804 1773 1784 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 NAB2</italic>
###xml 1843 1852 1823 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1900 1918 1880 1898 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 and yra1&#8211;8</italic>
###xml 685 690 <span type="species:ncbi:4932">yeast</span>
###xml 1438 1443 <span type="species:ncbi:4932">yeast</span>
###xml 2063 2068 <span type="species:ncbi:4932">yeast</span>
Because multiple mRNA export factors contribute to efficient mRNA export, we considered the possibility that the interaction between Nab2 and Mlp1 might contribute to a step in mRNA export that is not normally rate-limiting in a wild-type background. Thus, an effect on overall cellular function as assayed by cell growth might only be evident in a genetic background where additional steps in mRNA export are compromised or suboptimal. We therefore tested for genetic interactions between nab2 F72D or nab2 F73D and mRNA export mutants, mex67-5 (8) or yra1-8 (21), at the permissive growth temperature for these conditional mutants. Using the plasmid shuffle assay, NAB2Delta mex67-5 yeast cells harboring the NAB2 URA3 maintenance plasmid and containing NAB2, nab2 DeltaN, F72D or F73D LEU2 test plasmids were grown to saturation, serially diluted, and spotted on control and 5-FOA plates. The mex67-5 nab2 F73D double mutant cells show a slow growth phenotype compared with mex67-5 NAB2 cells, whereas mex67-5 nab2 F72D cells show growth similar to mex67-5 NAB2 cells (Fig. 6A). Further supporting a functional link between Mex67 and Nab2, mex67-5 nab2 DeltaN cells are not viable. We confirmed the slow growth phenotype of mex67-5 nab2 F73D cells relative to mex67-5 NAB2 cells by measuring the optical density of the cells in liquid cultures and generating quantitative growth curves (Fig. 6B). In a similar manner, NAB2Delta yra1-8 yeast cells harboring the NAB2 URA3 maintenance plasmid and containing NAB2, nab2 DeltaN, F72D or F73D LEU2 test plasmids were grown to saturation and spotted on control and 5-FOA plates. The yra1-8 nab2 F73D double mutant cells show a slow growth phenotype compared with yra1-8 NAB2 cells (Fig. 6A), whereas yra1-8 nab2 F72D cells show growth similar to yra1-8 NAB2 cells. These results demonstrate that nab2 F73D genetically interacts with mRNA export mutants mex67-5 and yra1-8 at their permissive temperatures. Together, the data suggest that although disrupting the Nab2 interaction with Mlp1 does not detectably impact yeast cell growth when the mRNA export pathway is fully functional, it does impact cell growth when mRNA export is suboptimal.
###end p 52
###begin p 53
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 13 125 13 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic>
###xml 9 170 9 170 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic> cells show nuclear poly(A) RNA accumulation.</bold>
###xml 170 190 170 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, mex67-5 nab2 F73D</italic>
###xml 200 216 200 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 nab2 F73D</italic>
###xml 253 257 253 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 263 270 259 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 274 278 270 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 284 290 276 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 313 322 305 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 346 356 338 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 362 374 350 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 379 393 367 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D LEU2</italic>
###xml 546 547 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 574 591 556 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 639 651 621 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 659 671 641 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 697 712 675 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 717 726 695 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 813 814 791 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 814 817 792 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 873 893 851 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, mex67-5 nab2 F73D</italic>
###xml 942 946 920 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 952 959 926 933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 980 995 954 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 1000 1009 974 983 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1080 1084 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 1085 1086 1053 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1304 1307 1272 1275 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1543 1548 1511 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1720 1732 1688 1700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1749 1766 1715 1732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F72D</italic>
###xml 1787 1804 1751 1768 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1826 1843 1788 1805 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1926 1938 1888 1900 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1954 1971 1916 1933 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F72D</italic>
###xml 2080 2097 2042 2059 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 9 2153 9 2115 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="54"><bold>The <italic>nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic> cells show nuclear poly(A) RNA accumulation.</bold><italic>A, mex67-5 nab2 F73D</italic> cells or <italic>yra1&#8211;8 nab2 F73D</italic> cells have a slow growth phenotype. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> or <italic>NAB2</italic>&#916; <italic>yra1&#8211;8</italic> cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>mex67-5 nab2 F73D</italic> cells confirms that they grow more slowly than <italic>mex67-5 NAB2</italic> cells. <italic>mex67-5 NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, mex67-5 nab2 F73D</italic> cells show nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 43 cells each (indicated to the <italic>right</italic> of the DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>mex67-5 NAB2</italic>, 18.6 &#177; 4.8%; <italic>mex67-5 nab2 F72D</italic>, 20.3 &#177; 6.0%; and <italic>mex67-5 nab2 F73D</italic>, 30.8 &#177; 6.9. Thus, <italic>mex67-5 nab2 F73D</italic> cells exhibit a 1.7-fold increase in nuclear poly(A) RNA accumulation relative to <italic>mex67-5 NAB2</italic> cells, whereas <italic>mex67-5 nab2 F72D</italic> cells show only a slight 1.1-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>mex67-5 nab2 F73D</italic> cells were typical of multiple independent experiments.</p>
###xml 9 2153 9 2115 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="54"><bold>The <italic>nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic> cells show nuclear poly(A) RNA accumulation.</bold><italic>A, mex67-5 nab2 F73D</italic> cells or <italic>yra1&#8211;8 nab2 F73D</italic> cells have a slow growth phenotype. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> or <italic>NAB2</italic>&#916; <italic>yra1&#8211;8</italic> cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>mex67-5 nab2 F73D</italic> cells confirms that they grow more slowly than <italic>mex67-5 NAB2</italic> cells. <italic>mex67-5 NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, mex67-5 nab2 F73D</italic> cells show nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 43 cells each (indicated to the <italic>right</italic> of the DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>mex67-5 NAB2</italic>, 18.6 &#177; 4.8%; <italic>mex67-5 nab2 F72D</italic>, 20.3 &#177; 6.0%; and <italic>mex67-5 nab2 F73D</italic>, 30.8 &#177; 6.9. Thus, <italic>mex67-5 nab2 F73D</italic> cells exhibit a 1.7-fold increase in nuclear poly(A) RNA accumulation relative to <italic>mex67-5 NAB2</italic> cells, whereas <italic>mex67-5 nab2 F72D</italic> cells show only a slight 1.1-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>mex67-5 nab2 F73D</italic> cells were typical of multiple independent experiments.</p></caption>
###xml 2153 2153 2115 2115 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200006"/>
###xml 0 2153 0 2115 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="54"><bold>The <italic>nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic> cells show nuclear poly(A) RNA accumulation.</bold><italic>A, mex67-5 nab2 F73D</italic> cells or <italic>yra1&#8211;8 nab2 F73D</italic> cells have a slow growth phenotype. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> or <italic>NAB2</italic>&#916; <italic>yra1&#8211;8</italic> cells maintained by a <italic>NAB2 URA3</italic> plasmid and containing <italic>NAB2, nab2</italic> &#916;<italic>N, nab2 F72D</italic>, or <italic>nab2 F73D LEU2</italic> test plasmids were grown to saturation, serially diluted in 10-fold dilutions and spotted on control and 5-FOA plates. Cells were grown at 30 &#176;C. <italic>B</italic>, growth curve analysis of <italic>mex67-5 nab2 F73D</italic> cells confirms that they grow more slowly than <italic>mex67-5 NAB2</italic> cells. <italic>mex67-5 NAB2</italic>&#916; cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown to saturation, diluted, and their optical density was measured at <italic>A</italic><sub>600</sub> for 40 h as described under &#8220;Experimental Procedures.&#8221; <italic>C, mex67-5 nab2 F73D</italic> cells show nuclear accumulation of poly(A) RNA. <italic>NAB2</italic>&#916; <italic>mex67-5</italic> cells carrying only <italic>NAB2, nab2 F72D</italic>, or <italic>nab2 F73D</italic> plasmids were grown in liquid culture at 30 &#176;C and poly(A) RNA (<italic>Poly</italic>(<italic>A</italic>)) was visualized by FISH using an oligo(dT) probe as described under &#8220;Experimental Procedures.&#8221; Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (<italic>DIC</italic>) images are shown. FISH results were quantitated as described under &#8220;Experimental Procedures&#8221; to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 43 cells each (indicated to the <italic>right</italic> of the DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: <italic>mex67-5 NAB2</italic>, 18.6 &#177; 4.8%; <italic>mex67-5 nab2 F72D</italic>, 20.3 &#177; 6.0%; and <italic>mex67-5 nab2 F73D</italic>, 30.8 &#177; 6.9. Thus, <italic>mex67-5 nab2 F73D</italic> cells exhibit a 1.7-fold increase in nuclear poly(A) RNA accumulation relative to <italic>mex67-5 NAB2</italic> cells, whereas <italic>mex67-5 nab2 F72D</italic> cells show only a slight 1.1-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in <italic>mex67-5 nab2 F73D</italic> cells were typical of multiple independent experiments.</p></caption><graphic xlink:href="zbc0430852200006"/></fig>
FIGURE 6.The nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1-8 and mex67-5 nab2 F73D cells show nuclear poly(A) RNA accumulation.A, mex67-5 nab2 F73D cells or yra1-8 nab2 F73D cells have a slow growth phenotype. NAB2Delta mex67-5 or NAB2Delta yra1-8 cells maintained by a NAB2 URA3 plasmid and containing NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D LEU2 test plasmids were grown to saturation, serially diluted in 10-fold dilutions and spotted on control and 5-FOA plates. Cells were grown at 30 degreesC. B, growth curve analysis of mex67-5 nab2 F73D cells confirms that they grow more slowly than mex67-5 NAB2 cells. mex67-5 NAB2Delta cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown to saturation, diluted, and their optical density was measured at A600 for 40 h as described under "Experimental Procedures." C, mex67-5 nab2 F73D cells show nuclear accumulation of poly(A) RNA. NAB2Delta mex67-5 cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown in liquid culture at 30 degreesC and poly(A) RNA (Poly(A)) was visualized by FISH using an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown. FISH results were quantitated as described under "Experimental Procedures" to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 43 cells each (indicated to the right of the DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: mex67-5 NAB2, 18.6 +/- 4.8%; mex67-5 nab2 F72D, 20.3 +/- 6.0%; and mex67-5 nab2 F73D, 30.8 +/- 6.9. Thus, mex67-5 nab2 F73D cells exhibit a 1.7-fold increase in nuclear poly(A) RNA accumulation relative to mex67-5 NAB2 cells, whereas mex67-5 nab2 F72D cells show only a slight 1.1-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in mex67-5 nab2 F73D cells were typical of multiple independent experiments.
###end p 53
###begin p 54
###xml 4 116 4 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic>
###xml 0 161 0 161 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The <italic>nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1&#8211;8 and mex67-5 nab2 F73D</italic> cells show nuclear poly(A) RNA accumulation.</bold>
###xml 161 181 161 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, mex67-5 nab2 F73D</italic>
###xml 191 207 191 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8 nab2 F73D</italic>
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 254 261 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 265 269 261 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 275 281 267 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yra1&#8211;8</italic>
###xml 304 313 296 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2 URA3</italic>
###xml 337 347 329 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2</italic>
###xml 353 365 341 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N, nab2 F72D</italic>
###xml 370 384 358 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D LEU2</italic>
###xml 537 538 519 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 565 582 547 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 630 642 612 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 650 662 632 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 688 703 666 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 708 717 686 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 804 805 782 783 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 805 808 783 786 <sub xmlns:xlink="http://www.w3.org/1999/xlink">600</sub>
###xml 864 884 842 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C, mex67-5 nab2 F73D</italic>
###xml 933 937 911 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 943 950 917 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 971 986 945 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 991 1000 965 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 1071 1075 1039 1043 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Poly</italic>
###xml 1076 1077 1044 1045 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1295 1298 1263 1266 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DIC</italic>
###xml 1534 1539 1502 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right</italic>
###xml 1711 1723 1679 1691 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1740 1757 1706 1723 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F72D</italic>
###xml 1778 1795 1742 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1817 1834 1779 1796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1917 1929 1879 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1945 1962 1907 1924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F72D</italic>
###xml 2071 2088 2033 2050 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
The nab2 F73D mutant displays genetic interactions with mRNA export mutants mex67-5 and yra1-8 and mex67-5 nab2 F73D cells show nuclear poly(A) RNA accumulation.A, mex67-5 nab2 F73D cells or yra1-8 nab2 F73D cells have a slow growth phenotype. NAB2Delta mex67-5 or NAB2Delta yra1-8 cells maintained by a NAB2 URA3 plasmid and containing NAB2, nab2 DeltaN, nab2 F72D, or nab2 F73D LEU2 test plasmids were grown to saturation, serially diluted in 10-fold dilutions and spotted on control and 5-FOA plates. Cells were grown at 30 degreesC. B, growth curve analysis of mex67-5 nab2 F73D cells confirms that they grow more slowly than mex67-5 NAB2 cells. mex67-5 NAB2Delta cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown to saturation, diluted, and their optical density was measured at A600 for 40 h as described under "Experimental Procedures." C, mex67-5 nab2 F73D cells show nuclear accumulation of poly(A) RNA. NAB2Delta mex67-5 cells carrying only NAB2, nab2 F72D, or nab2 F73D plasmids were grown in liquid culture at 30 degreesC and poly(A) RNA (Poly(A)) was visualized by FISH using an oligo(dT) probe as described under "Experimental Procedures." Cells were stained with DAPI to visualize the position of the nucleus. Corresponding differential interference contrast (DIC) images are shown. FISH results were quantitated as described under "Experimental Procedures" to assess the mean percentage of cells with nuclear accumulation of poly(A) RNA within 10 fields of at least 43 cells each (indicated to the right of the DIC images). Variation in the percentage of cells with nuclear poly(A) RNA in each field of cells from the mean was assessed by calculating the standard deviation: mex67-5 NAB2, 18.6 +/- 4.8%; mex67-5 nab2 F72D, 20.3 +/- 6.0%; and mex67-5 nab2 F73D, 30.8 +/- 6.9. Thus, mex67-5 nab2 F73D cells exhibit a 1.7-fold increase in nuclear poly(A) RNA accumulation relative to mex67-5 NAB2 cells, whereas mex67-5 nab2 F72D cells show only a slight 1.1-fold increase. The percentages of nuclear poly(A) RNA accumulation observed in mex67-5 nab2 F73D cells were typical of multiple independent experiments.
###end p 54
###begin p 55
###xml 15 24 15 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 151 158 151 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 362 379 362 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 551 558 545 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 615 616 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 619 623 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 629 636 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5</italic>
###xml 654 669 644 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2, nab2 F72D</italic>
###xml 674 683 664 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 767 784 757 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 869 881 859 871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 895 896 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 889 896 879 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6<italic>C</italic></xref>
###xml 1006 1013 996 1003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Given that the nab2 F73D cells showed a mild mRNA export defect in a wild-type background, we wished to assess whether cells expressing Nab2 F73D in a mex67-5 mRNA export mutant background, which showed a severe cell growth defect, exhibit a similar or more pronounced mRNA export defect. To address this possibility, we examined poly(A) RNA localization in the mex67-5 nab2 F73D cells and quantitated the percentage of cells with nuclear poly(A) RNA accumulation. Importantly, we examined the cells at the permissive temperature of 30 degreesC where mex67-5 cells show minimal nuclear accumulation of poly(A) RNA (8). NAB2Delta mex67-5 cells expressing NAB2, nab2 F72D, or nab2 F73D were processed for FISH with an oligo(dT) probe to visualize bulk poly(A) RNA. The mex67-5 nab2 F73D cells show a 1.7-fold increase in nuclear accumulation of poly(A) RNA compared with mex67-5 NAB2 cells (Fig. 6C). The combined results suggest that Nab2-F73D, which disrupts the Nab2/Mlp1 interaction, impacts mRNA export in vivo.
###end p 55
###begin title 56
DISCUSSION
###end title 56
###begin p 57
###xml 321 328 321 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 390 399 390 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 476 481 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEX67</italic>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YRA1</italic>
###xml 1071 1073 1071 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
###xml 1075 1077 1075 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref60">60</xref>
In this study, we have examined the functional significance of the interaction between the poly(A) RNA-binding protein, Nab2, and the nuclear pore-associated protein, Mlp1, to test a model where Nab2 facilitates targeting of mRNA for export via interaction with Mlp1. We find that disruption of the Nab2/Mlp1 interaction in vivo causes nuclear accumulation of poly(A) RNA. Furthermore, the nab2 F73D mutant shows genetic interactions with two genes essential for mRNA export, MEX67 and YRA1, supporting the hypothesis that Nab2 binding to Mlp1 contributes to efficient mRNA export. In addition, we have characterized the Nab2/Mlp1 interaction in detail and find that the Nab2-binding domain of Mlp1 (Mlp1-NBD) is sufficient to bind to the N-terminal domain of Nab2 (Nab2-N) and cause nuclear accumulation of poly(A) RNA, suggesting that Nab2 is an important molecular link between Mlp1 and poly(A) RNA. We also find that Mlp1-NBD binds to Nab2-N with micromolar affinity, indicating that the Nab2/Mlp1 interaction, like other mRNA export factor-nucleoporin interactions (59, 60), is comparatively weak. Together, the results are consistent with the notion that Nab2 facilitates targeting of mRNA for export via transient interaction with Mlp1 and acts in concert with other mRNA export factors to coordinate proper mRNA export.
###end p 57
###begin p 58
###xml 322 324 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref61">61</xref>
###xml 400 413 396 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces</italic>
###xml 883 885 875 877 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
We have mapped the Nab2-binding domain of Mlp1 (Mlp1-NBD) to a 183-amino acid region (residues 1586-1768) within CT-Mlp1. Analysis of the Mlp1-NBD protein sequence using Phyre () suggests that it forms a predominantly alpha-helical secondary structure, with the initial 90 residues (1586-1676) likely to form two helices (61). Sequence alignment of the Mlp1-NBD peptide with Mlp1 peptides from other Saccharomyces species highlights key hydrophobic residues within the first 90 residues of Mlp1-NBD that have been evolutionarily conserved and perhaps retained because they form alpha-helical secondary structure or serve as functional contact sites. It will be necessary to determine the structure of Mlp1-NBD and its complex with Nab2-N to define the Mlp1-NBD fold more precisely and identify the residues within Mlp1-NBD that make contact with the hydrophobic patch and residue Phe73 in Nab2-N.
###end p 58
###begin p 59
###xml 158 159 158 159 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 157 159 157 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 180 181 167 168 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 394 396 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
###xml 398 400 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref60">60</xref>
###xml 471 472 458 459 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 470 472 457 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 482 483 468 469 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 546 547 532 533 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 545 547 531 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 558 559 543 544 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 561 563 546 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref59">59</xref>
###xml 565 567 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref60">60</xref>
###xml 611 612 595 596 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 894 901 878 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Analysis of the binding between Nab2-N and Mlp1-NBD indicates that Mlp1-NBD binds to Nab2-N with a relatively weak affinity that is in the micromolar range (Kd approximately 1.3 mum). Apparent binding affinities between the nuclear transport factor, NTF2, or the mRNA receptor heterodimer, TAP-p15, and FG repeat-containing nucleoporins have been measured and are also in the micromolar range (59, 60). For example, NTF2 binds to FG repeat nucleoporins with an apparent Kd of 1-4 mum and TAP-p15 binds to FG repeat nucleoporins with an apparent Kd of 4-11 mum (59, 60). Therefore, the binding constant of 1.3 mum observed between Nab2 and Mlp1 is comparable with the binding constants measured between other nuclear transport factors and FG-nucleoporins. Like the low-affinity transport factor-nucleoporin interactions, the rather weak Nab2/Mlp1 interaction is therefore likely to be transient in vivo. In this way, Nab2 may bind transiently to Mlp1 with a relatively high off-rate consistent with rapid transport of the properly assembled mRNA export complex.
###end p 59
###begin p 60
###xml 230 238 230 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 273 275 273 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">73</sup>
###xml 430 431 430 431 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 429 431 429 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 452 453 439 440 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 489 490 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink">d</sub>
###xml 488 490 475 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">K<sub>d</sub></italic>
###xml 511 512 485 486 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
Quantitative analysis of the interaction between Nab2-N-F73D and Mlp1-NBD shows that Mlp1-NBD binding to Nab2-N-F73D is too weak to measure. This result supports previous data showing that CT-Mlp1 cannot interact with Nab2-N-F73D in vitro and confirms that Nab2 residue Phe73 is critical for the Nab2/Mlp1 interaction. In addition, we find that Mlp1-NBD binds to a second Nab2 mutant, Nab2-N-F73W, with 1.5-fold higher affinity (Kd approximately 0.8 mum) compared with wild-type protein (Kd approximately 1.3 mum). This result strengthens the idea that large hydrophobic residues within Nab2-N are important for binding to Mlp1 and underscores the hydrophobic nature of the Nab2/Mlp1 interaction.
###end p 60
###begin p 61
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 184 193 184 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 284 289 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MEX67</italic>
###xml 294 298 294 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YRA1</italic>
###xml 411 420 411 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 513 517 513 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NAB2</italic>
###xml 867 884 867 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 977 989 977 989 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 NAB2</italic>
###xml 1093 1110 1093 1110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1409 1426 1409 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1651 1668 1639 1656 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D mex67-5</italic>
###xml 1834 1843 1810 1819 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
A key finding of this study is that expression of Nab2 F73D and the consequent disruption of the Nab2/Mlp1 interaction in vivo causes nuclear accumulation of poly(A) RNA and that this nab2 F73D mutant displays genetic interactions with alleles of two genes essential for mRNA export, MEX67 and YRA1. This result indicates that the Nab2/Mlp1 interaction is functionally important and contributes to mRNA export. nab2 F73D cells show a 2.5-fold increase in nuclear accumulation of poly(A) RNA relative to wild-type NAB2 cells, but do not exhibit a detectable growth defect. A potential explanation for this result is that the Nab2/Mlp1 interaction increases the rate and/or efficiency of one step of the mRNA export pathway that is not normally rate-limiting and therefore the Nab2/Mlp1 interaction is not absolutely required for cell growth in a wild-type background. mex67-5 nab2 F73D cells, however, show a 1.7-fold increase in nuclear accumulation of poly(A) RNA relative to mex67-5 NAB2 cells and clearly exhibit a decrease in cell growth. One possible explanation for the growth defect in mex67-5 nab2 F73D cells is that the Nab2/Mlp1 interaction becomes critical for a cellular function, such as efficient mRNA export, when additional steps in mRNA export and/or mRNA metabolism are compromised due to impairment of the Mex67 mRNA export receptor. A second potential explanation for the growth defect in mex67-5 nab2 F73D cells is that a threshold number of cells that exhibit mRNA export defects within the population must be reached before any effects on the overall growth properties of the culture are observed. Thus, the approximately30% of nab2 F73D mex67-5 cells that show nuclear accumulation of poly(A) RNA may be sufficient to impact the overall growth properties of the cell population, whereas the approximately8% of nab2 F73D cells that show nuclear poly(A) RNA accumulation may not be sufficient. Further study will be required to ascertain precisely how defects in cell growth are linked to impaired mRNA export.
###end p 61
###begin p 62
###xml 233 234 233 234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 227 234 227 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>A</italic></xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref62">62</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 445 447 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 569 571 569 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 675 677 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 738 740 738 740 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 1090 1092 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1094 1096 1094 1096 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 1219 1221 1219 1221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref64">64</xref>
###xml 1223 1225 1223 1225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref65">65</xref>
###xml 1286 1288 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref66">66</xref>
###xml 1289 1291 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref69">69</xref>
###xml 1367 1369 1367 1369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref70">70</xref>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
###xml 1571 1573 1571 1573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref70">70</xref>
###xml 1575 1577 1575 1577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
The analysis of the Nab2 F73D mutant presented here and previous work on components of the mRNA export pathway suggest a model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export (Fig. 7A). In this simplified model, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (21, 62), and the poly(A) tails of the mRNA are specifically bound by Nab2 during or after polyadenylation (34-36). Yra1 binds to the mRNA export protein, Mex67 (18, 19), and recruits the Mex67/Mtr2 heterodimeric receptor to the mRNA (16). Mex67/Mtr2 then interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (17). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (38), via interaction between the Nab2-N hydrophobic patch and the Mlp1-NBD, to help concentrate the mRNA at the pore for interaction with other mRNA export factors and transport to the cytoplasm. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2, which interacts with FG-nucleoporins in the channel (17, 63). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (64, 65), which is bound to and activated by the nucleoporin, Gle1 (66-69), and Dbp5 remodels the mRNP to trigger dissociation of Nab2 from the RNA (70), release of Mex67, and disassembly of the complex (71). Importantly, examination of Dbp5 function suggests that disassembly of the mRNA export complex is probably a rate-limiting step in mRNA export (70, 71). In a more detailed mRNA export model, several other mRNA export adaptors, hnRNPs, and mRNA processing factors can be added that aid in the concentration of mRNA at the nuclear face of the pore, the translocation of that mRNA through the pore and its remodeling and disassembly at the cytoplasmic face of the pore.
###end p 62
###begin p 63
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 7.</label>
###xml 100 117 100 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 9 154 9 154 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature.</bold>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 346 348 346 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref62">62</xref>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 397 399 397 399 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 457 459 457 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 524 526 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 628 630 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 691 693 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 840 842 840 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 965 967 965 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref64">64</xref>
###xml 969 971 969 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref65">65</xref>
###xml 1023 1025 1023 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref66">66</xref>
###xml 1026 1028 1026 1028 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref69">69</xref>
###xml 1101 1103 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref70">70</xref>
###xml 1156 1158 1156 1158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
###xml 1161 1162 1161 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1228 1245 1228 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1463 1464 1463 1464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1466 1468 1466 1468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 9 2013 9 2013 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="64"><bold>Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature.</bold><italic>A</italic>, model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export. Initially, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref62">62</xref>), and bound by Nab2 at the poly(A) tail (<xref ref-type="bibr" rid="ref34">34</xref>&#8211;<xref ref-type="bibr" rid="ref36">36</xref>). Yra1 then binds to the mRNA export protein, Mex67 (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>), recruiting the Mex67/Mtr2 heterodimeric receptor to the mRNA (<xref ref-type="bibr" rid="ref16">16</xref>) and Mex67/Mtr2 interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (<xref ref-type="bibr" rid="ref17">17</xref>). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (<xref ref-type="bibr" rid="ref38">38</xref>), via the Nab2-N/Mlp1-NBD interaction. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2 (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref63">63</xref>). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (<xref ref-type="bibr" rid="ref64">64</xref>, <xref ref-type="bibr" rid="ref65">65</xref>), tethered and activated by the nucleoporin, Gle1 (<xref ref-type="bibr" rid="ref66">66</xref>&#8211;<xref ref-type="bibr" rid="ref69">69</xref>), which remodels the mRNP to trigger dissociation of Nab2 from the RNA (<xref ref-type="bibr" rid="ref70">70</xref>), release of Mex67, and disassembly of the complex (<xref ref-type="bibr" rid="ref71">71</xref>). <italic>B</italic>, model to explain the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature in which combined impairment of Mex67 and Nab2 reduces mRNA export. Here, the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref16">16</xref>), may also be impaired in binding to FG-nucleoporins at the permissive temperature, potentially resulting in a moderate reduction in the rate of translocation. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. Combination of the reduction in mRNA translocation rate produced by Mex67-5 and reduction in the mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA.</p>
###xml 9 2013 9 2013 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="64"><bold>Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature.</bold><italic>A</italic>, model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export. Initially, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref62">62</xref>), and bound by Nab2 at the poly(A) tail (<xref ref-type="bibr" rid="ref34">34</xref>&#8211;<xref ref-type="bibr" rid="ref36">36</xref>). Yra1 then binds to the mRNA export protein, Mex67 (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>), recruiting the Mex67/Mtr2 heterodimeric receptor to the mRNA (<xref ref-type="bibr" rid="ref16">16</xref>) and Mex67/Mtr2 interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (<xref ref-type="bibr" rid="ref17">17</xref>). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (<xref ref-type="bibr" rid="ref38">38</xref>), via the Nab2-N/Mlp1-NBD interaction. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2 (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref63">63</xref>). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (<xref ref-type="bibr" rid="ref64">64</xref>, <xref ref-type="bibr" rid="ref65">65</xref>), tethered and activated by the nucleoporin, Gle1 (<xref ref-type="bibr" rid="ref66">66</xref>&#8211;<xref ref-type="bibr" rid="ref69">69</xref>), which remodels the mRNP to trigger dissociation of Nab2 from the RNA (<xref ref-type="bibr" rid="ref70">70</xref>), release of Mex67, and disassembly of the complex (<xref ref-type="bibr" rid="ref71">71</xref>). <italic>B</italic>, model to explain the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature in which combined impairment of Mex67 and Nab2 reduces mRNA export. Here, the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref16">16</xref>), may also be impaired in binding to FG-nucleoporins at the permissive temperature, potentially resulting in a moderate reduction in the rate of translocation. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. Combination of the reduction in mRNA translocation rate produced by Mex67-5 and reduction in the mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA.</p></caption>
###xml 2013 2013 2013 2013 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0430852200007"/>
###xml 0 2013 0 2013 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig7"><label>FIGURE 7.</label><caption><p textid="64"><bold>Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature.</bold><italic>A</italic>, model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export. Initially, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (<xref ref-type="bibr" rid="ref21">21</xref>, <xref ref-type="bibr" rid="ref62">62</xref>), and bound by Nab2 at the poly(A) tail (<xref ref-type="bibr" rid="ref34">34</xref>&#8211;<xref ref-type="bibr" rid="ref36">36</xref>). Yra1 then binds to the mRNA export protein, Mex67 (<xref ref-type="bibr" rid="ref18">18</xref>, <xref ref-type="bibr" rid="ref19">19</xref>), recruiting the Mex67/Mtr2 heterodimeric receptor to the mRNA (<xref ref-type="bibr" rid="ref16">16</xref>) and Mex67/Mtr2 interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (<xref ref-type="bibr" rid="ref17">17</xref>). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (<xref ref-type="bibr" rid="ref38">38</xref>), via the Nab2-N/Mlp1-NBD interaction. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2 (<xref ref-type="bibr" rid="ref17">17</xref>, <xref ref-type="bibr" rid="ref63">63</xref>). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (<xref ref-type="bibr" rid="ref64">64</xref>, <xref ref-type="bibr" rid="ref65">65</xref>), tethered and activated by the nucleoporin, Gle1 (<xref ref-type="bibr" rid="ref66">66</xref>&#8211;<xref ref-type="bibr" rid="ref69">69</xref>), which remodels the mRNP to trigger dissociation of Nab2 from the RNA (<xref ref-type="bibr" rid="ref70">70</xref>), release of Mex67, and disassembly of the complex (<xref ref-type="bibr" rid="ref71">71</xref>). <italic>B</italic>, model to explain the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature in which combined impairment of Mex67 and Nab2 reduces mRNA export. Here, the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (<xref ref-type="bibr" rid="ref8">8</xref>, <xref ref-type="bibr" rid="ref16">16</xref>), may also be impaired in binding to FG-nucleoporins at the permissive temperature, potentially resulting in a moderate reduction in the rate of translocation. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. Combination of the reduction in mRNA translocation rate produced by Mex67-5 and reduction in the mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA.</p></caption><graphic xlink:href="zbc0430852200007"/></fig>
FIGURE 7.Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in mex67-5 nab2 F73D cells at the permissive temperature.A, model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export. Initially, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (21, 62), and bound by Nab2 at the poly(A) tail (34-36). Yra1 then binds to the mRNA export protein, Mex67 (18, 19), recruiting the Mex67/Mtr2 heterodimeric receptor to the mRNA (16) and Mex67/Mtr2 interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (17). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (38), via the Nab2-N/Mlp1-NBD interaction. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2 (17, 63). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (64, 65), tethered and activated by the nucleoporin, Gle1 (66-69), which remodels the mRNP to trigger dissociation of Nab2 from the RNA (70), release of Mex67, and disassembly of the complex (71). B, model to explain the observed growth and mRNA export defects in mex67-5 nab2 F73D cells at the permissive temperature in which combined impairment of Mex67 and Nab2 reduces mRNA export. Here, the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (8, 16), may also be impaired in binding to FG-nucleoporins at the permissive temperature, potentially resulting in a moderate reduction in the rate of translocation. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. Combination of the reduction in mRNA translocation rate produced by Mex67-5 and reduction in the mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA.
###end p 63
###begin p 64
###xml 91 108 91 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 0 145 0 145 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in <italic>mex67-5 nab2 F73D</italic> cells at the permissive temperature.</bold>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 337 339 337 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
###xml 341 343 341 343 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref62">62</xref>
###xml 385 387 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref34">34</xref>
###xml 388 390 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref36">36</xref>
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 448 450 448 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 619 621 619 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 682 684 682 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref38">38</xref>
###xml 827 829 827 829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 831 833 831 833 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref63">63</xref>
###xml 956 958 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref64">64</xref>
###xml 960 962 960 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref65">65</xref>
###xml 1014 1016 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref66">66</xref>
###xml 1017 1019 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref69">69</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref70">70</xref>
###xml 1147 1149 1147 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref71">71</xref>
###xml 1152 1153 1152 1153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1219 1236 1219 1236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1454 1455 1454 1455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1457 1459 1457 1459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
Models for Nab2 function in mRNA export and the observed growth and mRNA export defects in mex67-5 nab2 F73D cells at the permissive temperature.A, model for Nab2 function in mRNA export in which Nab2 helps to target mRNA to the nuclear pore for export. Initially, mRNA is co-transcriptionally loaded with the mRNA export adaptor, Yra1 (21, 62), and bound by Nab2 at the poly(A) tail (34-36). Yra1 then binds to the mRNA export protein, Mex67 (18, 19), recruiting the Mex67/Mtr2 heterodimeric receptor to the mRNA (16) and Mex67/Mtr2 interacts with FG-nucleoporins at the pore to translocate the mRNA to the cytoplasm (17). Alongside Yra1 and Mex67, Nab2 binds to Mlp1 at the pore (38), via the Nab2-N/Mlp1-NBD interaction. The assembled mRNA complex containing Nab2 is then translocated through the NPC channel by Mex67/Mtr2 (17, 63). Upon reaching the cytoplasmic face of the nuclear pore, the mRNA export complex encounters the DEAD-box helicase, Dbp5 (64, 65), tethered and activated by the nucleoporin, Gle1 (66-69), which remodels the mRNP to trigger dissociation of Nab2 from the RNA (70), release of Mex67, and disassembly of the complex (71). B, model to explain the observed growth and mRNA export defects in mex67-5 nab2 F73D cells at the permissive temperature in which combined impairment of Mex67 and Nab2 reduces mRNA export. Here, the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (8, 16), may also be impaired in binding to FG-nucleoporins at the permissive temperature, potentially resulting in a moderate reduction in the rate of translocation. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. Combination of the reduction in mRNA translocation rate produced by Mex67-5 and reduction in the mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA.
###end p 64
###begin p 65
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig7" ref-type="fig">Fig. 7<italic>B</italic></xref>
###xml 97 114 97 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 246 247 246 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 249 251 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 1295 1312 1295 1312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 1600 1617 1600 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
Fig. 7B presents a plausible model to account for the observed growth and mRNA export defects in mex67-5 nab2 F73D cells. We envisage that the Mex67-5 mutant, which cannot interact with Mtr2 and FG-nucleoporins at the non-permissive temperature (8, 16), may also be impaired in binding to FG-nucleoporins even at the permissive temperature. As the interaction between Mex67 and the FG-nucleoporins is necessary for the translocation step of mRNA export (17), the Mex67-5 mutant may reduce the rate of translocation through the nuclear pore. At the permissive temperature, this modest reduction in the rate of translocation produced by Mex67-5 may not impact the overall rate of mRNA export as the translocation step is probably not normally rate-limiting. Similarly, the Nab2 F73D mutant, which cannot interact with Mlp1, may reduce the rate of mRNA concentration at the pore. At the permissive temperature, this moderate reduction in the rate of mRNA concentration produced by Nab2 F73D may not affect the total rate of mRNA export as the concentration step is also probably not normally rate-limiting. However, the cumulative effect of impairing both mRNA translocation and concentration steps could be more marked and reduce the overall rate of mRNA export. At the permissive temperature, in mex67-5 nab2 F73D cells, the combined reduction in the mRNA translocation rate produced by Mex67-5 and the reduction in mRNA concentration rate caused by Nab2 F73D could become rate-limiting and result in a decreased rate of mRNA export coupled with nuclear accumulation of poly(A) RNA. Alternatively, in mex67-5 nab2 F73D cells, malformed mRNP complexes containing Nab2 F73D and Mex67-5 may be generated that are not recognized and removed by the surveillance machinery because Nab2 F73D does not bind to Mlp1 efficiently. Further work will be required to distinguish between these alternative models.
###end p 65
###begin p 66
###xml 87 94 87 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 358 367 358 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink">nab2 F73D</italic>
###xml 402 419 402 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">mex67-5 nab2 F73D</italic>
###xml 303 308 <span type="species:ncbi:4932">yeast</span>
The combined data presented here highlight the importance of the Nab2/Mlp1 interaction in vivo and underscore the extent of cooperation between mRNA export factors, Nab2, Yra1, and Mex67, that is necessary for efficient mRNA export. In addition, the data suggest that although the mRNA export system in yeast can tolerate single component mutations, such as nab2 F73D, double component mutations, like mex67-5 nab2 F73D, produce a growth defect and significant nuclear accumulation of poly(A) RNA, consistent with the step in the export pathway in which they participate becoming rate-limiting, even under permissive conditions. The results of this study are therefore consistent with a model in which Nab2 helps to target the mRNP complex to the nuclear pore via interaction with Mlp1 to facilitate mRNA export. In this model, it is clear that Nab2 acts in concert with other mRNA export factors, particularly Yra1 and Mex67, to form an mRNP that is competent of export. Future studies on the genetic and physical interactions between Nab2 and other mRNA export components will help to elucidate the underlying mechanism of mRNA export in eukaryotic organisms.
###end p 66
###begin title 67
Supplementary Material
###end title 67
###begin title 68
[Supplemental Data]
###end title 68
###begin p 69
We are most grateful to members of the Corbett laboratory for helpful discussions and comments. We also thank Richard P. Grant and Neil J. Marshall of the Stewart laboratory for structural analysis of the N-terminal domain of Nab2. In addition, we thank Susan R. Wente and Francoise Stutz for generously providing reagents.
###end p 69
###begin p 70
###xml 372 373 372 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S</italic>
###xml 578 585 578 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ</italic>
###xml 424 430 <span type="species:ncbi:9913">bovine</span>
The abbreviations used are: hnRNP, heterogeneous nuclear ribonucleoprotein; NPC, nuclear pore complex; FG-nucleoporin, phenylalanine-glycine repeat-containing nuclear pore protein; Mlp1, myosin-like protein 1; CT-Mlp1, C-terminal domain of Mlp1; Nab2-N, N-terminal domain of Nab2; Mlp1-NBD, Nab2-binding domain of Mlp1; Tpr, translocated promoter region; GST, glutathione S-transferase; PBS, phosphate-buffered saline; BSA, bovine serum albumin; GFP, green fluorescent protein; DAPI, 4',6-diamidino-2-phenylindole-dihydrochloride; 5-FOA, 5-fluoroorotic acid; FISH, fluorescence in situ hybridization; DTT, dithiothreitol.
###end p 70

